Publications issues de la recherche financée par le GTIC

Moura CS, Morrison LJ, Hohl CM, Grant L, Pilote L, Neville A, Hau JP, Bernatsky S et les chercheurs du Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) pour le Réseau canadien de recherche en urgence et le Groupe canadien de recherche en soins intensifs. Administrative data ICD‑10 diagnostic codes identifies most lab‑confirmed SARS‑CoV‑2 admissions but misses many discharged from the Emergency Department. Sci Rep. Le 12 mars 2024. doi : https://doi.org/10.1038/s41598-023-49501-7.

Datwani S, Kalikawe R, Waterworth R, Mwimanzi FM, Liang R, Sang Y, Lapointe HR, Cheung PK, Omondi FH, Duncan MC, Barad E, Speckmaier S, Moran-Garcia N, Demarco ML, Hedgcock M, Costiniuk CT, Hull M, Harris M, Romney MG, Montaner JSG, Brumme ZL, Brockman MA. Dynamics of T cell responses to COVID-19 vaccines and breakthrough infection in people living with HIV receiving antiretroviral therapy. medRxiv. Le 11 mars 2024. doi : https://doi.org/10.1101/2024.03.08.24304006

Coutu J, Ricard P, Djaïleb A, Lavallée E, Rabazanaha H, Stuible M, Durocher Y, Gilbert C, Brousseau N, Santerre, Thériault M, Trottier S, Boudreau D, Langlois MA, Pelletier J, Etchebarne MB, Masson JF. Large-scale validation of a plasmonic sensor for SARS-CoV-2 pseudo-neutralization with a cohort of food and retail workers. ChemRxiv. Le 15 décembre 2023. doi : 10.26434/chemrxiv-2023-3cwjs

Smith ER, Oakley E, Grandner GW, Rukundo G, Farooq F, Ferguson K, Baumann S, Adams Waldorf KM, Afshar Y, Ahlberg M, Ahmadzia H, Akelo V, Aldrovandi G, Bevilacqua E, Bracero N, Brandt JS, Broutet N, Carrillo J, Conry J, Cosmi E, Crispi F, Crovetto F, Del Mar Gil M, Delgado-López C, Divakar H, Driscoll AJ, Favre G, Fernandez Buhigas I, Flaherman V, Gale C, Godwin CL, Gottlieb S, Gratacós E, He S, Hernandez O, Jones S, Joshi S, Kalafat E, Khagayi S, Knight M, Kotloff KL, Lanzone A, Laurita Longo V, Le Doare K, Lees C, Litman E, Lokken EM, Madhi SA, Magee LA, Martinez-Portilla RJ, Metz TD, Miller ES, Money D, Moungmaithong S, Mullins E, Nachega JB, Nunes MC, Onyango D, Panchaud A, Poon LC, Raiten D, Regan L, Sahota D, Sakowicz A, Sanin-Blair J, Stephansson O, Temmerman M, Thorson A, Thwin SS, Tippett Barr BA, Tolosa JE, Tug N, Valencia-Prado M, Visentin S, von Dadelszen P, Whitehead C, Wood M, Yang H, Zavala R, Tielsch JM. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol. Février 2023;228(2):161-77. doi : 10.1016/j.ajog.2022.08.038.

McClymont E, Abenhaim H, Albert A, Boucoiran I, Cassell K, Castillo E, Crane J, Elwood C, Fell DB, Joynt C, Kotaska A, Murphy PA, Murphy-Kaulbeck L, Poliquin V, Ryan S, Saunders S, Scott H, Shah P, Snelgrove J, van Schalkwyk J, Yudin MH, Money D. Canadian Surveillance of COVID-19 in Pregnancy (CANCOVID-Preg): a rapidly coordinated national response using established regional infrastructures. J Obstet Gynaecol Can. Février 2021. doi :  https://doi.org/10.1016/j.jogc.2020.10.005

Antenatal Serostudies Project–September 27, 2022 Report. https://med-fom-ridprogram.sites.olt.ubc.ca/files/2022/11/Antenatal-Serostudies-Report-September-27-2022.pdf

Canadian Surveillance of COVID-19 in Pregnancy: Epidemiology, Maternal and Infant Outcomes. Rapport n^o 6, repéré à https://med-fom-ridprogram.sites.olt.ubc.ca/files/2023/11/CANCOVIDPreg_Report6_13Sep2023_FINAL_updated.pdf

Golding L, Watts AW, Shew J, Paramo MV, Mâsse LC, Goldfarb DM, Abu-Raya B, Lavoie PM. A novel anti-nucleocapsid antibody avidity method for identifying SARS-CoV-2 reinfections. J Infect Dis. Le 5 mars 2024. doi : https://doi.org/10.1093/infdis/jiae072

Almeida ND, Schiller I, Ke D, Sakr E, Plesa M, Vanamala S, Moneger AL, Bazan M, Lucchesi C, Wozniak N, Fritz JH, Piccirillo CA, Pelchat M, Arnold C, Galipeau Y, McCluskie PS, Langlois MA, Dasgupta K, Mazer BD. The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study. Front Immunol. Le 15 février 2024. doi : https://doi.org/10.3389/fimmu.2024.1330549

Enilama O, Yau K, Er L, Atiquzzaman M, Oliver MJ, Romney MG, Leis JA, Abe KT, Qi F, Colwill K, Gingras AC, Hladunewich MA, Levin A. Humoral response following 3 doses of mRNA COVID-19 vaccines in patients with Non-Dialysis-Dependent CKD: an observational study. Can J Kidney Health Dis. Le 29 janvier 2024. doi : doi.org/10.1177/20543581231224127

Cherry N, Adisesh A, Burstyn I, Durand-Moreau Q, Galarneau JM, Labrèche F, Ruzycki S, Zadunayski T. Work characteristics, workplace support and mental ill-health in a Canadian cohort of healthcare workers during the COVID-19 pandemic. J Occup Environ Med. Le 27 février 2024. doi : 10.1097/JOM.0000000000003074

Leeies M, Rosychuk RJ, Ismath M, Xu K, Archambault P, Fok PT, Audet T, Jelic T, Hayward J, Daoust R, Chandra K, Davis P, Yan JW, Hau JP, Welsford M, Brooks SC, Hohl CM; chercheurs du Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) pour le Réseau canadien de recherche en urgence, le Groupe canadien de recherche en soins intensifs. Intubation practices and outcomes for patients with suspected or confirmed COVID-19: a national observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN). CJEM. Avril 2023;25(4):335-43. doi : https://doi.org/10.1007/s43678-023-00487-1.

Davis P, Rosychuk R, Hau JP, Cheng I, McRae AD, Daoust R, Lang E, Turner J, Khangura J, Fok PT, Stachura M, Brar B, Hohl CM. Diagnostic yield of screening for SARS-CoV-2 among patients admitted to hospital for alternate diagnoses: an observational cohort study. BMJ Open. Le 12 juillet 2022. doi : 10.1136/bmjopen-2021-057852.

Azeez R, Lotoski L, Dubeau A, Rodriguez N, Reyna ME, Freitas T, Goguen S, Medeleanu M, Winsor GL, Brinkman FSL, Cameron EE, Roos L, Simons E, Moraes TJ, Mandhane PJ, Turvey SE, Bolotin S, Wright K, McNeil D, Patrick DM, Bullard J, Langlois MA, Arnold CR, Galipeau Y, Pelchat M, Doucas N, Subbarao P, Azad MB. Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort. Epidemiol Health. 2023;45:e2023091. doi : 10.4178/epih.e2023091.

Rosychuk RJ, Khangura JK, Ortiz SS, Cheng I, Bielska IA, Yan J, Morrison LJ, Hayward J, Grant L, Hohl CM; Canadian COVID-19 Rapid Response Network (CCEDRRN) pour le Réseau canadien de recherche en urgence (RéCRU). Characteristics and outcomes of patients with COVID-19 who return to the emergency department: a multicentre observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN). Emerg Med J. Le 16 février 2024:emermed-2023-213277. doi : 10.1136/emermed-2023-213277.

Pasat Z, Breznik JA, Rahim A, Zhang A, Ang J, Kajaks T, Miller MS, Bowdish DME, Costa AP. Examining the association between frailty and antibody neutralization of SARS-CoV-2: a multisite retrospective cohort study. J Am Med Dir Assoc. Le 5 février 2024. doi : 10.1016/j.jamda.2023.12.013

Hasing M, Yu J, Qiu Y, Maal-Bared R, Bhavanam S, Lee B, Hrudey S, Pang X. Comparison of detecting and quantitating SARS-CoV-2 in wastewater using moderate-speed centrifuged solids versus an ultrafiltration method. Water. Le 6 août 2021;13(16):2166. doi : https://doi.org/10.3390/w13162166

D’Aoust PM, Tian X, Towhid ST, Xiao A, Mercier E, Hegazy N, Jia JJ, Wan S, Kabir MP, Fang W, Fuzzen M, Hasing M, Yang MI, Sun J, Plaza-Diaz J, Zhang Z, Cowan A, Eid W, Stephenson S, Servos MR, Wade MJ, MacKenzie AE, Peng H, Edwards EA, Pang XL, Alm EJ, Graber TE, Delatolla R. Wastewater to clinical case (WC) ratio of COVID-19 identifies insufficient clinical testing, onset of new variants of concern and population immunity in urban communities. Sci Total Environ. Le 20 décembre 2022;853:158547. doi : 10.1016/j.scitotenv.2022.158547.

Thomas B, Flood CM, Krishnamurthy V, Tanner R, Wilson K. Human rights legislation and vaccination mandates. Institut C.D. Howe. Le 4 février 2022. https://www.cdhowe.org/intelligence-memos/thomas-flood-krishnamurthy-tanner-wilson-human-rights-legislation-and.

Richard L, Nisenbaum R, Colwill K, Mishra S, Dayam RM, Liu M, Pedersen C, Gingras A, Hwang SW. Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, Canada. BMC Infect Dis. Le 2 février 2024; doi : 10.1186/s12879-024-09013-9

Allen UD, Barton M, Upton J, Bailey A, Campigotto A, Abdulnoor M, Julien JP, Gubbay J, Kissoon N, Litosh A, La Neve R, Wong P, Allen A, Bailey R, Byrne W, Jagoowani R, Phillips C, Merreles-Pulcini M, Polack A, Prescod C, Siddiqi A, Summers A, Thompson K, Thompson S, James, C. Disproportionate rates of COVID‑19 among Black Canadian communities: lessons from a cross‑sectional study in the first year of the pandemic. J Racial Ethn Health Disparities. Le 22 janvier 2024; doi : 10.1007/s40615-023-01903-z

Sumner MW, Xie J, Zemek R, Winston K, Freire G, Burstein B, Kam A, Emsley J, Gravel J, Porter R, Sabhaney V, Mater A, Salvadori M, Berthelot S, Beer D, Poonai N, Moffat A, Wright B, Freedman SB, groupe d’étude sur la COVID de Pediatric Emergency Research Canada (PERC). Comparison of symptoms associated With SARS-CoV-2 variants among children in Canada. JAMA Netw Open. Le 9 mars 2023; doi : 10.1001/jamanetworkopen.2023.2328.

Law JC, Watts TH. Considerations for choosing T Cell assays during a pandemic. J Immunol. Le 15 juillet 2023;211(2):169-174. doi : 10.4049/jimmunol.2300129.

Hegazy N, Cowan A, D’Aoust PM, Mercier É, Towhid ST, Jia JJ, Wan S, Zhang Z, Kabir MP, Fang W, Graber TE, MacKenzie AE, Guilherme S, Delatolla R. Understanding the dynamic relation between wastewater SARS-CoV-2 signal and clinical metrics throughout the pandemic. Sci Total Environ. Le 20 décembre 2022;853:158458. doi : 10.1016/j.scitotenv.2022.158458.

Djaïleb A, Parker MF, Lavallée E, Stuible M, Durocher Y, Thériault M, Santerre K, Gilbert C, Boudreau D, Baz M, Masson JF, Langlois MA, Trottier S, Quaglia D, Pelletier JN. Longitudinal study on and immune response to SARS-CoV-2 in a population of food and retail workers through transformation of ELISA datasets. medRxiv. Le 29 janvier 2024. doi : 10.1101/2024.01.27.24301877.

Nantel S, Sheikh-Mohamed S, Chao GYC, Kurtesi A, Hu Q, Wood H, Colwill K, Li Z, Liu Y, Seifried L, Bourdin B, McGeer A, Hardy WR, Rojas OL, Al-Aubodah TA, Liu Z, Ostrowski MA, Brockman MA, Piccirillo CA, Quach C, Rini JM, Gingras AC, Decaluwe H, Gommerman JL. Comparison of Omicron Breakthrough Infection Versus Monovalent SARS-CoV-2 Intramuscular Booster Reveals Differences in Mucosal and Systemic Humoral Immunity. Mucosal Immunol Le 24 janvier 2024:S1933-0219(24)00004-7. doi : 10.1016/j.mucimm.2024.01.004.

Cherry N, Adisesh A, Burstyn I, Charlton C, Chen Y, Durand-Moreau Q, Labrèche F, Ruzycki S, Turnbull L, Zadunayski T, Yasui Y. Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: a prospective cohort study. Vaccine. Le 25 janvier 2024; doi : 10.1016/j.vaccine.2024.01.052.

Silverberg SL, Shulha HP, McMillan B, He G, Lee A, Márquez AC, Bartlett SR, Gill V, Abu-Raya B, Bettinger JA, Cabrera A, Coombs D, Gantt S, Goldfarb DM, Sauvé L, Krajden M, Morshed M, Sekirov I, Jassem AN, Sadarangani M. Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults. BMC Infect Dis. Le 15 janvier 2024. doi : https://doi.org/10.1186/s12879-023-08950-1.

McLaughlin KJ, Khanna M, Allison PJ, Glogauer M, McNally ME, Quiñonez C, Rock L, Siqueira W, Madathil SA. Investigating the perceptions and experiences of Canadian dentists on dental regulatory bodies’ communications and guidelines during the COVID-19 pandemic. Community Dent Oral Epidemiol. Le 8 janvier 2024. doi : 10.1111/cdoe.12939.

Parkins MD, Lee BE, Acosta N, Bautista M, Hubert CRJ, Hrudey SE, Frankowski K, Pang XL. Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond. Clin Microbiol Rev. Le 14 décembre 2023; doi : https://doi.org/10.1128/cmr.00103-22.

Kandasamy S, Chabrotra R, Khan Z, Rana D, Suddle N, Desai D, Khan F, Nocos R, Lear SA, Anand SS. Engaging participants through hybrid community-centered approaches: lessons learned during the COVID CommUNITY public health research program. Health Promot Pract. Le 5 janvier 2024:15248399231221161. doi : 10.1177/15248399231221161.

Hohl CM, McRae AD. Antiviral treatment for COVID-19: ensuring evidence is applicable to current circumstances. CMAJ 2022.07.25; doi : https://doi.org/10.1503/cmaj.221012.

Collins E, Galipeau Y, Arnold C, Bosveld C, Heiskanen A, Keeshan A, Nakka K, Shir-Mohammadi K, St-Denis-Bissonnette F, Tamblyn L, Vranjkovic A, Wood LC, Booth R, Buchan CA, Crawley AM, Little J, McGuinty M, Saginur R, Langlois MA, Cooper CL. Cohort profile: Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination. BMJ Open. Le 16 août 2022; doi : https://doi.org/10.1136/bmjopen-2022-062187.

Thomas B, Flood CM, Krishnamurthy V, Tanner R, Wilson K. Four privacy choices for vaccine passports. Document de travail de l’Institut C.D. Howe. Le 12 juillet 2021; https://www.cdhowe.org/intelligence-memos/thomas-flood-krishnamurthy-tanner-and-wilson-%E2%80%93-four-privacy-choices-vaccine

Galarneau J-M, Labrèche F, Durand-Moreau Q, Ruzycki S, Adisesh A, Burstyn I, Zadunayski T, Cherry N. Excess risk of COVID-19 infection and mental distress in healthcare workers during successive pandemic waves: Analysis of matched cohorts of healthcare workers and community referents in Alberta, Canada. Can J Public Health. Le 16 janvier 2024. doi : 10.17269/s41997-023-00848-4. Duong S, Burtniak J, Gretchen A, Mai A, Klassen P, Wei Y, Loeppky C, Shaw SY, Bullard J, Caeseele PV, Stein DR. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020–February 2022. BMC Public Health. Le 5 décembre 2023; doi : https://doi.org/10.1186/s12889-023-17239-6.

Halvorson T, Ivison S, Huang Q, Ladua G, Yotis DM, Mannar D, Subramaniam S, Ferreira VH, Kumar D, Belga S, Levings MK. SARS-CoV-2 variants Omicron BA.4/5 and XBB.1.5 significantly escape T cell recognition in solid organ transplant recipients vaccinated against the ancestral strain. Transplantation. Le 28 novembre 2023; doi : 10.1097/TP.0000000000004873.

Asamoah-Boaheng M, Grunau B, Karim ME, Jassem AN, Bolster J, Marquez AC, Scheuermeyer FX, Goldfarb DM. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination? Front Immunol. Le 8 septembre 2022;13:954093. doi : https://doi.org/10.3389/fimmu.2022.954093.

Wilson M, Qiu Y, Yu J, Lee BE, McCarthy DT, Pang X. Comparison of Auto Sampling and Passive Sampling Methods for SARS-CoV-2 Detection in Wastewater. Pathogens. Le 16 mars 2022;11(3):359. doi : https://doi.org/10.3390/pathogens11030359.

Hohl CM, Hau JP, Vaillancourt S, Grant J, Brooks SC, Morrison LJ, Perry JJ, Rosychuk RJ; chercheurs du CCEDRRN pour le Réseau canadien de recherche en urgence et le Groupe canadien de recherche en soins intensifs. Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital. JAMA Netw Open. Le 3 octobre 2022;5(10):e2236288. doi : https://doi.org/10.1001/jamanetworkopen.2022.36288.

Asamoah-Boaheng M, Goldfarb D, Prusinkiewicz MA, Golding L, Karim ME, Barakauskas V, Wall N, Jassem AN, Marquez AC, MacDonald C, O’Brien SF, Lavoie P, Grunau B. Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity. Cureus. Le 31 janvier 2023;15(1):e34465. doi : https://doi.org/10.7759/cureus.34465.

Khanna M, Allison P, Farmer J, Quiñonez C, Glogauer M, Siqueira WL, Rock LD, McNally M, Madathil S. Personal protective equipment during COVID-19. JADA. Décembre 2023; doi : https://doi.org/10.1016/j.adaj.2023.09.017

Richard L, Nisenbaum R, Brown M, Liu M, Pedersen C, Jenkinson JIR, Mishra S, Baral S, Colwill K, Gingras AC, McGeer A, Hwang SW. Incidence of SARS-CoV-2 Infection Among People Experiencing Homelessness in Toronto, Canada. JAMA Network Open. Le 13 mars 2023;6(3):e232774; doi : 10.1001/jamanetworkopen.2023.2774

Roushani J, Thomas D, Oliver MJ, Ip J, Yeung A, Tang Y, Brimble KS, Levin A, Hladunewich MA, Cooper R, Blake PG. Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics. CJAN. Le 18 avril 2023;18:465-474; doi : 10.2215/CJN.0000000000000087.

Lee DID, Vanderhout S, Aglipay M, Birken CS, Morris SK, Piché‑Renaud, Keown-Stoneman CDG, Maguire JL. Delay in childhood vaccinations during the COVID‑19 pandemic. Can J Public Health. Le 20 janvier 2022;113:126-134. doi : https://doi.org/10.17269/s41997-021-00601-9

Rhodes JS, Aumon A, Morin S, Girard M, Larochelle C, Lahav B, Brunet-Ratnasingham E, Zhang W, Cutler A, Zhou A, Kaufmann DE, Zandee S, Prat A, Wolf G, Moon KR. Gaining Biological Insights through Supervised Data Visualization. medRxiv. Le 23 novembre 2023; doi : https://doi.org/10.1101/2023.11.22.568384.

Kandola K. Age-stratified SARS-CoV-2 Serological Prevalence Estimation Using Anonymized Residual Sera Following Delta and Omicron Waves in the Northwest Territories (NWT). Résultats non publiés. Le 22 novembre 2023. https://www.covid19immunitytaskforce.ca/fr/seroprevalence-au-canada/#tno

Lee N, Nguyen L, Austin PC, Brown KA, Grewal R, Buchan SA, Nasreen S, Gubbay J, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC. Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults. Clin Infect Dis. Le 24 novembre 2023:ciad716. doi : https://doi.org/10.1093/cid/ciad716.

Datwani S, Kalikawe R, Mwimanzi F, Speckmaier S, Liang R, Sang Y, Waterworth R, Yaseen F, Lapointe HR, Barad E, DeMarco ML, Holmes DT, Simons J, Montaner JSG, Romney MG, Brumme ZL, Brockman MA. Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults. Pathog Imm; le 17 novembre 2023. doi : https://doi.org/10.20411/pai.v8i1.613.

Abubakar H, Valdez C, Lovblum E, Ravindran R, Clarke R, Colwill K, Dayam RM, Gingras A-C, Walmsley S, pour le compte de l’équipe de recherche STOPCOV. Feasibility and Acceptability of Self-Collected Dried Blood Spots for SARS-CoV-2 Vaccine Response in Community-Dwelling Elderly: A Large Decentralized Prospective Study. J Community Med Public Health. Le 26 avril 2023. doi : https://doi.org/10.29011/2577-2228.100309.

Keeshan A, Galipeau Y, Heiskanen A, Collins E, McCluskie PS, Arnold C, Saginur R, Booth R, Little J, McGuinty M, Buchan CA, Crawley A, Langlois MA, Cooper C. Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralization efficiency to SARS-CoV-2 infection and vaccination. BMJ Open. Le 31 octobre 2023;13(10):e077714. doi : 10.1136/bmjopen-2023-077714.

Abu-Raya B, Reicherz F, Michalski C, Viñeta Paramo M, Majdoubi A, Golding L, Granoski M, Stojic A, Marchant DJ, Lavoie PM. Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation Measures. J Pediatric Infect Dis Soc. Le 8 novembre 2023:piad099. doi : 10.1093/jpids/piad099.

Kabbani D, Yotis DM, Ferreira VH, Shalhoub S, Belga S, Tyagi V, Ierullo M, Kulasingam V, Hébert MJ, West L, Delisle JS, Racine N, De Serres SA, Cardinal H, Dieudé M, Humar A, Kumar D. Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study. Open Forum Infect Dis. Le 13 avril 2023;10(5):ofad200. doi : https://doi.org/10.1093/ofid/ofad200.

Daroya E, Gaspar M, Grey C, Lessard D, Klassen B, Skakoon-Sparling S, Sinno J, Adam B, Perez-Brumer A, Lachowsky NJ, Sang JM, Hart TA, Cox J, Tan DHS, Grace D. “It’s different for heterosexuals”: exploring cis-heteronormativity in COVID-19 public health directives and its impacts on Canadian gay, bisexual, and queer men. Crit Public Health. Le 28 juin 2023:1-1. doi : https://doi.org/10.1080/09581596.2023.2226807.

Qiu Y, Yu J, Pabbaraju K, Lee BE, Gao T, Ashbolt NJ, Hrudey SE, Diggle M, Tipples G, Maal-Bared R, Pang X. Validating and optimizing the method for molecular detection and quantification of SARS-CoV-2 in wastewater. Sci Total Environ. Le 15 mars 2022;812:151434. doi : 10.1016/j.scitotenv.2021.151434.

Ma X, Li Z, Whelan MG, Kim D, Cao C, Yanes-Lane M, Yan T, Jaenisch T, Chu M, Clifton DA, Subissi L, Bobrovitz N, Arora RK. Serology Assays Used in SARS-CoV-2 Seroprevalence Surveys Worldwide: A Systematic Review and Meta-Analysis of Assay Features, Testing Algorithms, and Performance. Vaccines (Basel). Le 24 novembre 2022;10(12):2000. doi : https://doi.org/10.3390/vaccines10122000.

Cherry N, Adisesh A, Burstyn I, Durand-Moreau Q, Galarneau JM, Labrèche F, Ruzycki SM, Zadunayski T. Cohort profile: recruitment and retention in a prospective cohort of Canadian healthcare workers during the COVID-19 pandemic. BMJ Open. Le 1^er novembre 2023;13(11):e074716. doi : 10.1136/bmjopen-2023-074716.

Jorgensen SCJ, Drover SSM, Fell DB, Austin PC, D’Souza R, Guttmann A, Buchan SA, Wilson SE, Nasreen S, Schwartz KL, Tadrous M, Wilson K, Kwong JC. Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy. JAMA Pediatr. Le 23 octobre 2023:e234499. doi : 10.1001/jamapediatrics.2023.4499.

Yau K, Tam P, Chan CT, Hu Q, Qi F, Abe KT, Kurtesi A, Jiang Y, Estrada-Codecido J, Brown T, Liu L, Siwakoti A, Leis JA, Levin A, Oliver MJ, Colwill K, Gingras AC, Hladunewich MA. BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients. Clin J Am Soc Nephrol. Le 17 octobre 2023. doi : 10.2215/CJN.0000000000000328.

N’Guessan A, Kailasam S, Mostefai F, Poujol R, Grenier JC, Ismailova N, Contini P, De Palma R, Haber C, Stadler V, Bourque G, Hussin JG, Shapiro BJ, Fritz JH, Piccirillo CA. Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping and sequence analysis. iScience. Le 13 juillet 2023;26(8):107394. doi : 10.1016/j.isci.2023.107394.

Puyat JH, Wilton J, Fowokan A, Janjua NZ, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Lauscher D, Strong M, Burchell AN, Anis A, Samji H; équipe de l’étude COVAXHIV. COVID-19 vaccine effectiveness by HIV status and history of injection drug use: a test-negative analysis. J Int AIDS Soc. Octobre 2023;26(10):e26178. doi : https://doi.org/10.1002/jia2.26178.

Hammond K, Lee T, Vulesevic B, Singer J, Needham J, Burchell AN, Samji H, Walmsley S, Hull M, Jenabian MA, Routy JP, Margolese S, Mandarino E, Anis AH, Cooper CL, Costiniuk CT. Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIV. AIDS Res Ther. Le 20 octobre 2023;20(1):73. doi : https://doi.org/10.1186/s12981-023-00571-7.

Grey C, Sinno J, Zhang H, Daroya E, Skakoon-Sparling S, Klassen B, Lessard D, Hart TA, Cox J, Stewart M, Grace D. Queering public health: A critical examination of healthcare access and gender expression among trans, nonbinary, and other gender nonconforming people during COVID-19. Health & Social Care in the Community. Le 4 mars 2023; doi : https://doi.org/10.1155/2023/6676318

Silverberg SL, Shulha HP, McMillan B, He G, Lee A, Márquez AN, Bartlett SR, Gill V, Abu-Raya B, Bettinger JA, Cabrera A, Coombs D, Gantt S, Goldfarb DM, Sauvé L, Krajden M, Morshed M, Sekirov I, Jassem AN, Sadarangani M. Factors associated with severe acute respiratory syndrome-related coronavirus 2 infection in unvaccinated children and young adults. medRxiv. Le 18 août 2023; doi : https://doi.org/10.1101/2023.08.13.23294036.

McClymont E, Atkinson A, Albert A, Av-Gay G, Andrade J, Barrett J, Bogler T, Boucoiran I, Castillo E, D’Souza R, El-Chaâr D, Fadel S, Fell DB, Korchinski I, Kuret V, Ogilvie G, Poliquin V, Sadarangani M, Scott H, Snelgrove JW, Tunde-Byass M, Money D; équipe COVERED. Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study. Vaccine. Le 19 octobre 2023:S0264-410X(23)01215-X. doi : https://doi.org/10.1016/j.vaccine.2023.10.032.

Norton NJ, Ings DP, Fifield KE, Barnes DA, Barnable KA, Harnum DOA, Holder KA, Russell RS, Grant MD. Characteristics of vaccine- and infection-induced systemic IgA anti-SARS-CoV-2 spike responses. Vaccines (Basel). Le 7 septembre 2023 7;11(9):1462. doi : https://doi.org/10.3390/vaccines11091462.

Hutchison SM, De-Jongh González O, Watts A, Oberle E, Gadermann A, Goldfarb DM, Oberlander TF, Lavoie PM, Mâsse LC. Anxiety symptoms, psychological distress, and optimism in school staff: Testing associations with stressors and coping during the second year of the COVID-19 pandemic. J Affect Disord Reports. Le 6 octobre 2023. doi : https://doi.org/10.1016/j.jadr.2023.100662.

Reddon H, Barker B, Bartlett S, Márquez AC, Sekirov I, Jassem A, Morshed M, Clemens A, Beck McGreevy P, Hayashi K, DeBeck K, Krajden M, Milloy MJ, Socías ME. Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada. Sci Rep. Le 20 octobre 2023;13(1):17930. doi : https://doi.org/10.1038/s41598-023-44069-8.

Skakoon‐Sparling S, Palma PA, Zahran A, Hart TA, Moore DM, Cox J, Lachowsky NJ, Dvorakova M, Daroya E, Grace D. Loneliness and the sexual behavior of sexual minority men in the context of the COVID‐19 pandemic. Soc Personal Psychol Compass. Le 20 juin 2023;e12814. doi : https://doi.org/10.1111/spc3.12814

Thomas B, Flood CM, Krishnamurthy V, Tanner R, Wilson K. Vaccine Ins and Outs: An Exploration of the Legal Issues Raised by Vaccine Passports. Institut C.D. Howe. Le 29 juillet 2021. https://www.cdhowe.org/intelligence-memos/thomas-flood-krishnamurthy-tanner-wilson-%E2%80%93-are-vaccine-passports-discriminatory.

Grewal R, Buchan SA, Nguyen L, Nasreen S, Austin PC, Brown KA, Gubbay J, Lee N, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC. Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada: a Canadian Immunization Research Network (CIRN) Study. J Infect Dis. Le 5 octobre 2023:jiad419. doi : 10.1093/infdis/jiad419.

Parham KA, Kim GN, Richer CG, Ninkov M, Wu K, Saeedian N, Li Y, Rashu R, Barr SD, Arts EJ, Haeryfar SMM, Kang CY, Troyer RM. Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T cells against SARS-CoV-2 variants. iScience. Le 21 avril 2023;26(4):106292. doi : https://doi.org/10.1016/j.isci.2023.106292.

Nayyerabadi M, Fourcade L, Joshi SA, Chandrasekaran P, Chakravarti A, Massé C, Paul ML, Houle J, Boubekeur AM, DuSablon C, Boudreau V, Bovan D, Darbinian E, Coleman EA, Vinci S, Routy JP, Hétu PO, Poudrier J, Falcone EL. Vaccination after developing long COVID: impact on clinical presentation, viral persistence and immune responses. Int J Infect Dis. Le 15 septembre 2023:S1201-9712(23)00720-8. doi : 10.1016/j.ijid.2023.09.006.

Lee N, Nguyen L, Austin PC, Brown KA, Grewal R, Buchan SA, Nasreen S, Gubbay J, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC. Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults. medRxiv. Le 25 août 2023. doi : https://doi.org/10.1101/2023.08.24.23294503.

Galarneau J-M, Labrèche F, Durand-Moreau Q, Ruzycki S, Adisesh A, Burstyn I, Zadunayski T, Cherry N. Excess risk of Covid-19 infection and mental distress in healthcare workers during successive pandemic waves. Analysis of matched cohorts of healthcare workers and community referents in Alberta, Canada. medRxiv. Le 12 septembre 2023. doi : https://doi.org/10.1101/2023.09.12.23295439.

Cherry N, Adisesh A, Burstyn I, Charlton C, Chen Y, Durand-Moreau Q, Labrèche F, Ruzycki S, Turnbull L, Zadunayski T, Yasui Y. Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: a prospective cohort study. medRxiv. Le 13 septembre 2023. doi : https://doi.org/10.1101/2023.09.12.23295445.

Azeez R, Lotoski L, Winsor GL, Arnold CR, Galipeau Y, Pelchat M, Goguen S, Simons E, Moraes TJ, Mandhane PJ, Turvey SE, Bolotin S, Patrick DM, Bullard J, Lix LM, Doucas N, Rodriguez N, Brinkman FSL, Subbarao P, M-A, Azad MB. Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort. medRxiv. Le 6 septembre 2023. 23294696; doi : https://doi.org/10.1101/2023.09.06.23294696.

Santerre K, Thériault M, Brousseau N, Rochette S, Pelletier J-N, Gilbert C, Masson J-F, Baz M, Boudreau D, Trottier S. Cohort Profile: Prospective Cohort to Study the COVID-19 Immune Response in Retail Workers in Québec, Canada (CISACOV). medRxivI. Le 18 août 2023. 23294172; doi : https://doi.org/10.1101/2023.08.18.23294172

Paramo MV, Ngo LPN, Abu-Raya B, Reicherz F, Xu RY, Bone JN, Srigley JA, Solimano A, Goldfarb DM, Skowronski DM, Lavoie PM. Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational study. Lancet Reg. Health – Am. https://doi.org/10.1016/j.lana.2023.100582. 

Zinszer K, Charland K, Pierce L, Saucier A, Hamelin MÈ, Da Torre MB, Carbonneau J, Nguyen CT, De Serres G, Papenburg J, Boivin G, Quach C. Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada. Influenza Other Respir Viruses. 2023 Aug 25;17(8):e13186. doi: 10.1111/irv.13186.

Rabezanahary H, Gilbert C, Santerre K, Scarrone M, Gilbert M, Theriault M, Brousseau N, Masson J-M, Pelletier JN, Boudreau D, Trottier S, Baz M. Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Quebec, Canada. medRxiv. doi: https://doi.org/10.1101/2023.09.03.23294976.

Halvorson T, Ivison S, Huang Q, Ladua G, Yotis DM, Mannar D, Subramaniam S, Ferreira VH, Kumar D, Belga S, Levings MK. SARS-CoV-2 variants Omicron BA.4/5 and XBB.1.5 significantly escape T cell recognition in solid organ transplant recipients vaccinated against the ancestral strain. medRxiv 2023.08.14.23293991; doi: https://doi.org/10.1101/2023.08.14.23293991

Mittal A, Solera JT, Ferreira VH, Kothari S, Kimura M, Pasic I, Mattsson JI, Humar A, Kulasingam V, Ierullo M, Kumar D, Hosseini-Moghaddam SM. Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplant Recipients.Transplant Cell Ther. 2023 Aug 13:S2666-6367(23)01465-3. doi: 10.1016/j.jtct.2023.08.008.

Adisesh A, Durand-Moreau Q, Labrèche F, Ruzycki S, Zadunayski T, Cherry N. Determinants of sickness absence duration after mild COVID-19 in a prospective cohort of Canadian health care workers. J Occup Environ Med. 2023 Aug 14. doi: 10.1097/JOM.0000000000002945.

Murmann M, Reed AC, Scott M, Presseau J, Heer C, May K, Ramzy A, Huynh CN, Skidmore B, Welch V, Little J, Wilson K, Brouwers M, Hsu AT. Exploring COVID-19 education to support vaccine confidence amongst the general adult population with special considerations for healthcare and long-term care staff: A scoping review. Campbell Syst Rev. 2023 Aug 13;19(3):e1352. doi: https://doi.org/10.1002/cl2.1352.

Grey C, Tian IL, Skakoon-Sparling S, Daroya E, Klassen B, Lessard D, Gaspar M, Sinno J, Sang JM, Perez-Brumer A, Lachowsky NJ, Moore DM, Jollimore J, Hart TA, Cox J, Grace D. Unpacking racism during COVID-19: narratives from racialized Canadian gay, bisexual, and queer men. Int J Equity Health. 2023 Aug 8;22(1):152. doi: 10.1186/s12939-023-01961-z. (Available open access)

Aglipay M, Maguire J, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, Birken C, Kwong JC. mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. medRxiv 2023.06.27.23291933; doi: https://doi.org/10.1101/2023.06.27.23291933

Lu RXZ, Rafatian N, Zhao Y, Wagner KT, Beroncal EL, Li B, Lee C, Chen J, Churcher E, Vosoughi D, Wang Y, Baker A, Trahtemberg U, Li B, Pierro A, Andreazza AC, dos Santos CC, Radisic M. Heart-on-a-chip model of immune-induced cardiac dysfunction reveals the role of free mitochondrial DNA and therapeutic effects of endothelial exosomes. bioRxiv. doi: https://doi.org/10.1101/2023.08.09.552495.

Murphy TJ, Swail H, Jain J, Anderson M, Awadalla P, Behl L, MSc, Brown PE, Charlton CL,  Colwill K,  Drews SD, Gingras AC, Hinshaw D, Jha P, Kanji JN, Kirsh VA, Lang ALS, Langlois MA, Lee S, Lewin A, O’Brien SF, Pambrun C, Skead K, Stephens DA, Stein DR,  Tipples G, Van Caeseele P, Evans TE, Oxlade O, Mazer BD, Buckeridge DL. The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023. CMAJ 2023 14 août;195:E1030-7. doi: 10.1503/cmaj.230949

Whelan M, Galipeau Y, White-Al Habeeb N, Konforte D, Abou El Hassan M, Booth RA, Arnold C, Langlois MA, Pelchat M. Cross-sectional characterization of SARS-CoV-2 antibody levels and decay rates following infection of unvaccinated elderly Individuals. Open Forum Infect Dis. 2023 Jul 20;10(8):ofad384. doi: https://doi.org/10.1093/ofid/ofad384.

Breznik, JA, Rahim A, Zhang A, Ang J, Stacey HD, Bhakta H, Clare R, Liu LM, Kennedy A, Hagerman M, Kajaks T, Miller MS, Nazy I, Bramson JL, Costa AP, Bowdish DME. Early Omicron infection associated with increased infection risk in older adults in long-term care and retirement facilities. eClinicalMedicine 2023 août 2023;102148. doi.org/10.1016/j.eclinm.2023.102148

Costiniuk CT, Singer J, Lee T, Galipeau Y, McCluskie PS, Arnold C, Langlois MA, Needham J, Jenabian MA, Burchell AN, Samji H, Chambers C, Walmsley S, Ostrowski M, Kovacs C, Tan DHS, Harris M, Hull M, Brumme ZL, Lapointe HR, Brockman MA, Margolese S, Mandarino E, Samarani S, Vulesevic B, Lebouche B, Angel JB, Routy JP, Cooper CL, Anis AH; COVAXHIV Study Group. Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328). AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003680.

Collins E, Galipeau Y, Arnold C, Bhéreur A, Booth R, Buchan CA, Cooper C,  Crawley AM, Mccluskie P, McGuinty M, Pelchat M, Rocheleau L, Saginur R, Gravel C, Hawken S, Langlois MA, Little J. Clinical and serological predictors of Post COVID-19 Condition: Findings from a Canadian prospective cohort study. medRxiv 2023.07.29.23293334; doi: https://doi.org/10.1101/2023.07.29.23293334.

Abu-Raya B, Reicherz F, Michalski C, Majdoubi A, Golding L, Vienta M, Granoski M, Stojic A, Marchant DJ, Lavoie PM. Loss of severe respiratory syncytial virus infection-associated antibody function during the peak of the COVID-19 pandemic mitigation measures. medRxiv 2023 Aug 2. doi: https://doi.org/10.1101/2023.07.30.23292881.

Datwani S, Kalikawe R, Mwimanzi F, Speckmaier S, Liang R, Sang Y, Waterworth R, Yaseen F, Lapointe HR, Barad E, DeMarco ML, Holmes DT, Simons J, Montaner JSG, Romney MG, Brumme ZL, Brockman MA. Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults. medRxiv 2023.07.14.23292660; doi: https://doi.org/10.1101/2023.07.14.23292660

Juwono S, Luis Flores Anato J, Kirschbaum AL, Metheny N, Dvorakova M, Skakoon-Sparling S, Moore DM, Grace D, Hart TA, Lambert G, Lachowsky NJ, Jollimore J, Cox J, Maheu-Giroux M. Prevalence, determinants, and trends in the experience and perpetration of intimate partner violence among a cohort of gay, bisexual, and other men who have sex with men in Montréal, Toronto, and Vancouver, Canada (2017-2022). medRxiv 25 juillet . Doi: https://doi.org/10.1101/2023.07.24.23293112

Fell DB, Dimanlig-Cruz S, Török E, Håberg SE, Regan AK, Kaufman JS, Platt RW, Gravel CA, Bruce L, Shah PS, Wilson K, Sprague AE, Alton GD, Dhinsa T, El-Chaâr D, Buchan SA, Kwong JC, Wilson SE, Dunn SI, MacDonald SE, Barrett J, Okun N, Walker MC. Pregnancy, fetal, and neonatal outcomes following a first booster dose of COVID-19 vaccine during pregnancy in Ontario, Canada: a population-based retrospective cohort study. BMJ Medicine. Doi: http://dx.doi.org/10.1136/bmjmed-2023-000632.

Puyat JH, Fowokan A, Wilton J, Janjua NZ, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Lauscher D, Strong M, Burchell AN, Anis A, Samji H. Risk of COVID-19 Hospitalization in People Living with HIV and HIV-Negative Individuals and the Role of COVID-19 Vaccination: A Retrospective Cohort Study. Int J Infect Dis. 2023 Jul 5:S1201-9712(23)00650-1. doi: 10.1016/j.ijid.2023.06.026.

Atiquzzaman M, Zheng Y, Er L, Djurdjev O, Singer J, Krajden M, Balamchi S, Thomas D, Hladunewich M, Oliver MJ, Levin A. COVID-19 vaccine effectiveness among patients with maintenance dialysis; Observations from population level cohort studies in 2 large Canadian provinces. Can J Kidney Health Dis. 21 juin 2023;10:20543581231181032. doi: https://doi.org/10.1177/20543581231181032.

Perlman-Arrow S, Loo N, Bobrovitz N, Yan T, Arora RK. A real-world evaluation of the implementation of NLP technology in abstract screening of a systematic review. Res Synth Methods. 25 mai 2023. doi: https://doi.org/10.1002/jrsm.1636.

Ritchie G, Young M, Prystajecky N, Romney MG, Lowe CF, Matic N. Adaptability of single nucleotide polymorphism (SNP)-PCR for subtyping SARS-CoV-2 and a new SNP-PCR for XBB, XBB.1.5, and B.Q.1/B.Q.1.1. Clin Microbiol Infect. 15 juin 2023:S1198-743X(23)00292-6. doi: 10.1016/j.cmi.2023.06.014.

Daroya E, Grey C, Klassen B, Lessard D, Skakoon-Sparling S, Perez-Brumer A, Adam B, Cox J, Lachowsky NJ, Hart TA, Gervais J, Tan DHS, Grace D. ‘It’s not as good as the face-to-face contact’: A sociomaterialist analysis of the use of virtual care among Canadian gay, bisexual and queer men during the COVID-19 pandemic. Sociol Health Illn. 15 juin 2023. doi: https://doi.org/10.1111/1467-9566.13686.

Seth R, Madathil SA, Siqueira WL, McNally M, Quiñonez CR, Glogauer M, Allison PJ. Validity and reliability of the COVID-19 Anxiety Syndrome Scale in Canadian dentists. Clin Psychol Psychother. 20 juin 2023. doi: https://doi.org/10.1002/cpp.2877.

Matveev VA, Mihelic EZ, Benko E, Budylowski P, Grocott S, Lee T, Korosec CS, Colwill K, Stephenson H, Law R, Ward LA, Sheikh-Mohamed S, Mailhot G, Delgado-Brand M, Pasculescu A, Wang JH, Qi F, Tursun T, Kardava L, Chau S, Samaan P, Imran A, Copertino Jr DC, Chao G, Choi Y, Reinhard RJ, Kaul R, Heffernan JM, Jones RB,  Chun TW, Moir S, Singer J, Gommerman J, Gingras AC, Kovacs C, Ostrowski M. Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV. bioRxiv 2023.06.14.544834; doi: https://doi.org/10.1101/2023.06.14.544834.

Brunet-Ratnasingham E, Morin S, Randolph HE, Labrecque M, Bélair J, Lima-Barbosa R, Pagliuzza A, Marchitto L, Hultström M, Niessl J, Cloutier R, Flores AMS, Brassard N, Benlarbi M, Prévost J, Ding S, Anand SP, Sannier G, Bareke E,  Zeberg H, Lipcsey M, Frithiof R, Larsson A, Zhou S, Nakanishi T, Morrison D, Vezina D, Bourassa C, Gendron-Lepage G, Medjahed H, Point F, Richard J,  Larochelle C, Prat A, Arbour N, Durand M, Richards JB, Moon K, Chomont N, Finzi A, Tétreault M, Barreiro L, Wolf G, Kaufmann DE. Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity. medRxiv 2023.06.14.23290814. doi: https://doi.org/10.1101/2023.06.14.23290814

Cheng B, Loeschnik E, Selemon A, Hosseini R, Yuan J, Ware H, Ma X, Cao C, Bergeri I, Subissi L, Lewis HC, Williamson T, Ronksley P, Arora RK, Whelan M, Bobrovitz N. Adherence of SARS-CoV-2 seroepidemiologic studies to the ROSES-S reporting guideline during the COVID-19 pandemic. medRxiv 2023.06.02.23290895; doi: https://doi.org/10.1101/2023.06.02.23290895.

Jennifer Gommerman, Omicron breakthrough infection induces superior mucosal and humoral immunity to SARS-CoV-2 variants than booster vaccination, presented at the CITF Scientific Meeting, March 8-10, 2023.

Tania Watts, Lessons learned from monitoring T cell responses to SARS-CoV-2 infection and vaccination, presented at the CITF Scientific Meeting, Vancouver, Canada. March 8-10, 2023.

Grant MD, Bentley K, Fielding CA, Hatfield KM, Ings DP, Harnum D, Wang E, Stanton R, Holder KA. Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies. JCI Insight. 20 juin 2023. DOI: https://doi.org/10.1172/jci.insight.170681.

Lin YJ, Evans DH, Robbins NF, Orjuela G, Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Yi QL, O’Brien SF, Drews SJ. Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021. Microbiol Spectr. 8 juin 2023:e0525622. doi: 10.1128/spectrum.05256-22.

Cheung MW, Dayam RM, Shapiro JR, Law JC, Chao GYC, Pereira D, Goetgebuer RL, Croitoru D, Stempak JM, Acheampong L, Rizwan S, Lee JD, Jacob L, Ganatra D, Law R, Rodriguez-Castellanos VE, Kern-Smith M, Delgado-Brand M, Mailhot G, Haroon N, Inman RD, Piguet V, Chandran V, Silverberg MS, Watts TH, Gingras AC. Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases. J Immunol. 16 juin 2023:ji2300190. doi: 10.4049/jimmunol.2300190.

Watts AW, Mâsse LC, Goldfarb DM, Irvine MA, Hutchison SM, Muttucomaroe L, et al. SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada. BMJ Open. 2023;13(6):e071228. doi: http://dx.doi.org/10.1136/bmjopen-2022-071228.

Kolbe RJ, Madathil SA, Marin LM, Seth R, Faraj N, Allison PJ, Quiñonez C, Glogauer M, Siqueira WL, Siqueira MF. Salivary cortisol and anxiety in Canadian dentists over 1 year of COVID-19. J Dent Res. 15 juin 2023:220345231178726. doi: https://doi.org/10.1177/00220345231178726.

Archambault PM, Rosychuk RJ, Audet M, Bola R, Vatanpour S, Brooks SC, Daoust R, Clark G, Grant L, Vaillancourt S, Welsford M, Morrison LJ, Hohl CM; Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) investigators; Network of Canadian Emergency Researchers; Canadian Critical Care Trials Group. Accuracy of self-reported COVID-19 vaccination status compared with a public health vaccination registry in Québec: Observational Diagnostic Study. JMIR Public Health Surveill. 16 juin 2023;9:e44465. doi: https://doi.org/10.2196/44465.

Török E, Dhinsa T, Dimanlig-Cruz S, Alton GD, Sprague AE, Dunn SI, Shah PS, El-Chaâr D, Regan AK, Wilson K, Buchan SA, Kwong JC, Håberg SE, Gravel CA, Okun N, Walker MC, MacDonald SE, Wilson SE, Barrett J, Fell DB. Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancy. Hum Vaccin Immunother. 30 mai 2023:2215150. doi: https://doi.org/10.1080/21645515.2023.2215150.

Markovinović A, Quan J, Herauf M, Hracs L, Windsor JW, Sharifi N, Coward S, Caplan L, Gorospe J, Ernest-Suarez K, Ma C, Panaccione R, Ingram RJM, Kanji JN, Tipples G, Holodinsky JK, Bernstein CN, Mahoney DJ, Bernatsky S, Benchimol EI, Kaplan GG; STOP COVID-19 in IBD Research Group; STOP COVID-19 in IBD Research Group. Adverse Events & Serological Responses Following SARS-CoV-2 Vaccination in Individuals with Inflammatory Bowel Disease. Am J Gastroenterol. 22 mai 2023. doi: 10.14309/ajg.0000000000002337.

Ravindran R, Szadkowski L, Lovblom LE, Clarke R, Huang QW, Manase D, Parente L, Walmsley S; STOPCoV research team. Decentralized study of COVID Vaccine Antibody Response (STOPCoV): Results of a participant satisfaction survey. PLOS Digit Health. 9 mai 2023;2(5):e0000242. doi: https://doi.org/10.1371/journal.pdig.0000242.

McAlister FA, Hau JP, Atzema C, McRae AD, Morrison LJ, Grant L, Cheng I, Rosychuk RJ, Hohl CM; Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) Investigators. The burden of incidental SARS-CoV-2 infections in hospitalized patients across pandemic waves in Canada. Sci Rep. 2023 Apr 24;13(1):6635. doi: https://doi.org/10.1038/s41598-023-33569-2.

Wong MK, Liu JT, Budylowksi P, Yue FY, Li Z, Rini JM, Carlyle JR, Zia A, Ostrowski M, Martin A. Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine. Clin Immunol. 2022 Apr;237:108963. doi: 10.1016/j.clim.2022.108963. Epub 2022 Mar 5. Erratum in: Clin Immunol. 3 mai 2023. doi: https://doi.org/10.1016/j.clim.2022.108963.

Yoo S, Garg E, Elliott LT, Hung RJ, Halevy AR, Brooks JD, Bull SB, Gagnon F, Greenwood C, Lawless JF, Paterson AD, Sun L, Zawati MH, Lerner-Ellis J, Abraham R, Birol I, Bourque G, Garant JM, Gosselin C, Li J, Whitney J, Thiruvahindrapuram B, Herbrick JA, Lorenti M, Reuter MS, Adeoye OO, Liu S, Allen U, Bernier FP, Biggs CM, Cheung AM, Cowan J, Herridge M, Maslove DM, Modi BP, Mooser V, Morris SK, Ostrowski M, Parekh RS, Pfeffer G, Suchowersky O, Taher J, Upton J, Warren RL, Yeung R, Aziz N, Turvey SE, Knoppers BM, Lathrop M, Jones S, Scherer SW, Strug LJ. HostSeq: a Canadian whole genome sequencing and clinical data resource. BMC Genom Data. 2 mai 2023;24(1):26. doi: https://doi.org/10.1186/s12863-023-01128-3.

Su CY, Zhou S, Gonzalez-Kozlova E, Butler-Laporte G, Brunet-Ratnasingham E, Nakanishi T, Jeon W, Morrison DR, Laurent L, Afilalo J, Afilalo M, Henry D, Chen Y, Carrasco-Zanini J, Farjoun Y, Pietzner M, Kimchi N, Afrasiabi Z, Rezk N, Bouab M, Petitjean L, Guzman C, Xue X, Tselios C, Vulesevic B, Adeleye O, Abdullah T, Almamlouk N, Moussa Y, DeLuca C, Duggan N, Schurr E, Brassard N, Durand M, Del Valle DM, Thompson R, Cedillo MA, Schadt E, Nie K, Simons NW, Mouskas K, Zaki N, Patel M, Xie H, Harris J, Marvin R, Cheng E, Tuballes K, Argueta K, Scott I; Mount Sinai COVID-19 Biobank Team; Greenwood CMT, Paterson C, Hinterberg MA, Langenberg C, Forgetta V, Pineau J, Mooser V, Marron T, Beckmann ND, Kim-Schulze S, Charney AW, Gnjatic S, Kaufmann DE, Merad M, Richards JB. Circulating proteins to predict COVID-19 severity. Sci Rep. 2023 Apr 17;13(1):6236. doi: 10.1038/s41598-023-31850-y.

Zinszer K, Charland K, Pierce L, Saucier A, McKinnon B, Hamelin MÈ, Cheriet I, Da Torre MB, Carbonneau J, Nguyen CT, De Serres G, Papenburg J, Boivin G, Quach C. Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montreal, Canada. Int J Infect Dis. 2023 Mar 22:S1201-9712(23)00115-7. doi: https://doi.org/10.1016/j.ijid.2023.03.036.

Walmsley SL, Szadkowski L, Wouters B, Clarke R, Colwill K, Rochon P, Brudno M, Ravindran R, Raboud J, McGeer A, Oza A, Graham C, Silva A, Manase D, Maksymowsky P, Parente L, Dayam RM, Simpson J, Pasculescu A, Gingras AC. COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series. iScience. 2023 Apr 21;26(4):106506. doi: 10.1016/j.isci.2023.106506.

Ramandip Grewal, Sarah A Buchan, Lena Nguyen, Sharifa Nasreen, Peter C. Austin, Kevin A. Brown, Jonathan Gubbay, Nelson Lee, Kevin L Schwartz, Mina Tadrous, Kumanan Wilson, Sarah E Wilson, Jeffrey C Kwong. Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada. medRxiv 2023.04.11.23288403; doi: https://doi.org/10.1101/2023.04.11.23288403.

Grant MD, Bentley K, Fielding CA, Hatfield KM, Ings DP, Harnum D, Wang E, Stanton R, Holder KA. Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies. medRxiv. March 2023. DOI: 10.1101/2023.03.09.531709

Cherry N, Adisesh A, Burstyn I, Durand-Moreau Q, Galarneau JM, Labrèche F, Ruzycki S, Zadunayski T. Cohort profile: Recruitment and retention in a prospective cohort of Canadian health care workers during the Covid-19 pandemic. medRxiv. 2023 Apr 17. doi: https://doi.org/10.1101/2023.04.14.23288575.

Bazin R, Rochette S, Perreault J, Fournier MJ, Grégoire Y, Boivin A, Lewin A, Germain M, Renaud C. Evaluation of anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence in a vaccinated population. Infect Dis (Lond). 2023 Apr 11:1-6. doi: https://doi.org/10.1080/23744235.2023.2195938.

Ferreira VH, Ierullo M, Mavandadnejad F, Kurtesi A, Hu Q, Hardy WR, Hall VG, Pinzon N, Yotis D, Gingras AC, Belga S, Shalhoub S, Hébert MJ, Humar A, Kabbani D, Kumar D; PREVenT Study Group. Omicron BA.4/5 neutralization and T-cell responses in organ transplant recipients after Booster mRNA vaccine: a Multicenter Cohort Study. Clin Infect Dis. 2023 Mar 28:ciad175. doi: 10.1093/cid/ciad175.

Atkinson A, Albert A, McClymont E, Andrade J, Beach L, Bolotin S, Boucoiran I, Bullard J, Charlton C, Crane J, Dougan S, Forest JC, German GJ, Giguère Y, Girouard G, Hankins C, Krajden M, Lang A, Levett P, Minion J, Neudorf C, Poliquin V, Robinson JL, Scott H, Stein DR, Tran V, Zahariadis G, Zhou HY, Money D; Antenatal Serostudies Team. Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study. CMAJ Open. 2023 Apr 4;11(2):E305-E313. doi: https://doi.org/10.9778/cmajo.20220045.

Bodner K, Irvine MA, Kwong JC, Mishra S. Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational Covid-19 studies. Int J Infect Dis. 2023 Mar 27:S1201-9712(23)00102-9. doi: 10.1016/j.ijid.2023.03.022.

Breznik JA, Rahim A, Kajaks T, Hagerman M, Bilaver L, Colwill K, Dayam RM, Gingras AC, Verschoor CP, McElhaney JE, Bramson JL, Bowdish DME, Costa AP. Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada. J Am Med Dir Assoc. 2023 Mar 28:S1525-8610(23)00228-1. doi: 10.1016/j.jamda.2023.02.105.

Kandasamy S, Manoharan B, Khan Z, Stennett R, Desai D, Nocos R, Wahi G, Banner D, de Souza RJ, Lear SA, Anand SS. Perceptions of COVID-19 risk, vaccine access and confidence: a qualitative description of South Asians in Canada. BMJ Open. 2023 Apr 4;13(4):e070433. doi: 10.1136/bmjopen-2022-070433.

Burrows AG, Linton S, Thiele J, Sheth PM, Evans GA, Archer S, Doliszny KM, Finlayson M, Flynn L, Huang Y, Kasmani A, Hugh Guan T, Maier A, Hansen-Taugher A, Moore K, Sanfilippo A, Snelgrove-Clarke E, Tripp DA, Walker DMC, Vanner S, Ellis AK. Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence setting. Allergy Asthma Clin Immunol. 2023 Mar 29;19(1):25. doi: https://doi.org/10.1186/s13223-023-00769-4.

Khan AA, Sbihi H, Irvine MA, Jassem AN, Joffres Y, Klaver B, Janjua N, Bharmal A, Ng CH, Wilmer A, Galbraith J, Romney MG, Henry B, Hoang LMN, Krajden M, Hogan CA. Prediction of SARS-CoV-2 transmission dynamics based on population-level cycle threshold values: A Machine Learning and mechanistic modeling study. medRxiv. 2023 Mar 6. doi: https://doi.org/10.1101/2023.03.06.23286837.

Cheung MW, Dayam RM, Shapiro JR, Law JC, Chao GYC, Pereira D, Goetgebuer RL, Croitoru D, Stempak JM, Acheampong L, Rizwan S, Lee JD, Jacob L, Ganatra D, Law R, Rodriguez-Castellanos VE, Kern-Smith M, Delgado-Brand M, Mailhot G, Haroon N, Inman RD, Piguet V, Chandran V, Silverberg MS, Watts TH, Gingras AC. Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients. medRxiv 2023.03.01.23286513; doi: https://doi.org/10.1101/2023.03.01.23286513.

Yau K, Enilama O, Levin A, Romney MG, Singer J, Blake P, Perl J, Leis JA, Kozak R, Tsui H, Bolotin S, Tran V, Chan CT, Tam P, Dhruve M, Kandel C, Estrada-Codecido J, Brown T, Siwakoti A, Abe KT, Hu Q, Colwill K, Gingras A-C, Oliver MJ and Hladunewich MA. Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol. Canadian Journal of Kidney Health and Disease. March 2023. DOI: 10.1177/20543581231160511.

Boucher E, Cao C, D’Mello S, Duarte N, Donnici C, Duarte N, Bennett G, SeroTracker Consortium, Adisesh A, Arora R, Kodama D, Bobrovitz N. Occupation and SARS-CoV-2 seroprevalence studies: a systematic review. BMJ Open. February 2023. DOI: 10.1136/bmjopen-2022-063771.

Jorgensen SCJ, Hernandez A, Fell DB, Austin PC, D’Souza R, Guttmann A, Kwong JC. Estimated effectiveness of postpartum maternal messenger RNA COVID-19 vaccination against Delta and Omicron SARS-CoV-2 infection and hospitalization in infants younger than 6 months. JAMA Pediatr. 2023 Feb 27. doi: https://doi.org/10.1001/jamapediatrics.2022.6134.

Desgagnés, JS, Désy, O, Thivierge, MP, Marcoux, M, Béland, S, De Serres, SA. SARS-Cov-2 Antibody Levels That Confer Immune Protection Based on Neutralization of the Omicron Variant. Transplantation, March 23, 2023. DOI: 10.1097/TP.0000000000004596.

Naveed Z, Li J, Naus M, García HAV, Wilton J, Janjua NZ; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. A Population-Based Assessment of Myocarditis Following mRNA COVID-19 booster Vaccination Among Adult Recipients. Int J Infect Dis. 2023 Mar 24:S1201-9712(23)00106-6. doi: 10.1016/j.ijid.2023.03.027.

Patel, P., Li, X., Keown-Stoneman, C. D., Vanderloo, L. M., Kinlin, L. M., Maguire, J. L., & Birken, C. S. (2023). Changes in Pediatric Movement Behaviors During the COVID-19 Pandemic by Stages of Lockdown in Ontario, Canada: A Longitudinal Cohort Study, Journal of Physical Activity and Health, 20(4), 292-302. https://doi.org/10.1123/jpah.2022-0393

Buchan SA, Alley S, Seo CY, Johnson C, Kwong JC, Nasreen S, Thampi N, Lu D, Harris TM, Calzavara A, Wilson SE. Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada. JAMA Pediatr. 2023 Feb 27:e226166. doi: 10.1001/jamapediatrics.2022.6166.

Piché-Renaud PP, Swayze S, Buchan SA, Wilson SE, Austin PC, Morris SK, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson K, Kwong JC; CANADIAN IMMUNIZATION RESEARCH NETOWRK (CIRN) Provincial Collaborative Investigators. COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization. Pediatrics. March 2023. DOI: 10.1542/peds.2022-059513

Grewal R, Nguyen L, Buchan SA, Wilson SE, Nasreen S, Austin PC, Brown KA, Fell DB, Gubbay JB, Schwartz KL, Tadrous M, Wilson K, Kwong JC. Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes. Nature Communications. March 2023. DOI: 10.1038/s41467-023-36566-1

Germain M, Lewin A, Bazin R, Dieudé M, Perreault J, Boivin A, Grégoire Y, Renaud C. Cohort profile: A Quebec-based plasma donor biobank to study COVID-19 immunity (PlasCoV). BMJ Open. February 2023. DOI: 10.1136/bmjopen-2022-068803.

Wigle J, Hodwitz K, Juando-Prats C, Allan K, Li X, Howard L, Fallon B, Birken CS, Maguire JL, Parsons JA. Parents’ perspectives on SARS-CoV-2 vaccinations for children: a qualitative analysis. CMAJ. 2023 Feb 21;195(7):E259-E266. doi: 10.1503/cmaj.221401.

Alexandrova Y, Yero A, Mboumba Bouassa R-S, Comeau E, Samarani S, Brumme ZL, Hull M, Crawley AM, Langlois M-A, Angel JB, Cooper CL, Needham J, Lee T, Singer J, Anis AH, Costiniuk CT, Jenabian M-A. SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study). Viruses. February 2023. DOI: 10.3390/v15020575

Cheung PK, Lapointe HR, Sang Y, Ennis S, Mwimanzi F, Speckmaier S, Barad E, Dong W, Liang R, Simons J, Lowe CF, Romney MG, Brumme CJ, Niikura M, Brockman MA, Brumme ZL. COVID-19 vaccine immunity study team. SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART. AIDS. 2023 Feb 14. doi: 10.1097/QAD.0000000000003519.

Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Kalikawe R, Datwani S, Burns L, Young L, Leung V, Ennis S, Brumme CJ, Montaner JSG, Dong W, Prystajecky N, Lowe CF, DeMarco ML, Holmes DT, Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA, Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine, Open Forum Infectious Diseases, 2023, ofad073, doi: https://doi.org/10.1093/ofid/ofad073.

Fell DB, Török E, Sprague AE, Regan AK, Dhinsa T, Alton GD, Dimanlig-Cruz S, MacDonald SE, Buchan SA, Kwong JC, Wilson SE, Håberg SE, Gravel CA, Wilson K, Dunn SI, Shah PS, El-Chaâr D, Barrett J, Walker MC, Okun N, Dougan SD. Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study. Vaccine. 2023 Feb 3. doi: https://doi.org/10.1016/j.vaccine.2023.01.073.

Cherry N, Mhonde T, Adisesh A, Burstyn I, Durand-Moreau Q, Labrèche F, Ruzycki S. The evolution of workplace risk for Covid-19 in Canadian healthcare workers and its relation to vaccination: A nested case-referent study. Am J Ind Med. 2023 Feb 3. doi: https://doi.org/10.1002/ajim.23466.

Bola R, Sutherland J, Murphy RA, Leeies M, Grant L, Hayward J, Archambault P, Graves L, Rose T, Hohl C. Patient-reported health outcomes of SARS-CoV-2–tested patients presenting to emergency departments: a propensity score–matched prospective cohort study. Public Health. February 2023. DOI: 10.1016/j.puhe.2022.11.016.

Tauzin A, Nicolas A, Ding S, Benlarbi M, Medjahed H, Chatterjee D, Dionne K, Gong SY, Gendron-Lepage G, Bo Y, Perreault J, Goyette G, Gokool L, Arlotto P, Morrisseau C, Tremblay C, Martel-Laferrière V, De Serres G, Levade I, Kaufmann DE, Côté M, Bazin R, Finzi A. Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine. Cell Rep. 2023 Jan 31;42(1):111998. doi: 10.1016/j.celrep.2023.111998.

Jorgensen SCJ, Hernandez A, Fell DB, Austin PC, D’Souza R, Guttmann A, Brown KA, Buchan SA, Gubbay JB, Nasreen S, Schwartz KL, Tadrous M, Wilson K, Kwong JC, on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study. BMJ. February 2023. DOI: 10.1136/bmj-2022-074035.

Naylor KL, McArthur E, Dixon SN, Kwong JC, Thomas D, Balamchi S, Blake PG, Garg AX, Atiqazaaman M, Hladunewich MA, Levin A, Yeung A, Oliver MJ. Impact of study design on vaccine effectiveness estimates of two mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease. Kidney International. January 2023. DOI: 10.1016/j.kint.2023.01.009.

Hazlewood GS, Colmegna I, Hitchon C, Fortin PR, Bernatsky S, Clarke AE, Mosher D, Wilson T, Thomas M, Barber C, Harrison M, Bansback N, Proulx L, Richards DP, Kaplan GG. Preferences for COVID-19 vaccination in people with chronic immune-mediated inflammatory diseases. J Rheumatol. 2023 Jan 15:jrheum.220697. doi: 10.3899/jrheum.220697.

Tauzin A, Benlarbi M, Medjahed H, Grégoire Y, Perreault J, Gendron-Lepage G, Gokool L, Morrisseau C, Arlotto P, Tremblay C, Kaufmann DE, Martel-Laferrière V, Levade I, Côté M, De Serres G, Bazin R, Finzi A. Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination. Vaccines. 2023; 11(2):242. https://doi.org/10.3390/vaccines11020242.

O’Brien SF, Goldman M, Drews SJ. An expanded role for blood donor emerging pathogens surveillance. CMAJ. January 2023. doi: 10.1503/cmaj.147635-l.

Lin K, Xu K, Daoust R, Taylor J, Rosychuk RJ, Hau JP, Davis P, Clark G, McRae AD, Hohl CM & the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) investigators for the Network of Canadian Emergency Researchers, the Canadian Critical Care Trials Group. Prognostic association between d-dimer thresholds and 30-day pulmonary embolism diagnosis among emergency department patients with suspected SARS-CoV-2 infection: a Canadian COVID-19 Emergency Department Rapid Response Network study. Canadian Journal of Emergency Medicine. January 2023. DOI: 10.1007/s43678-022-00440-8.

Bergeri I, Whelan M, Ware H, Subissi L, Nardone A, Lewis HC, Li Z, Ma X, Valenciano M, Cheng B, Al Ariqi L, Rashidian A, Okeibunor J, Azim T, Wijesinghe P, Le LV, Vaughan A, Pebody R, Vicari A, Yan T, Yanes-Lane M, Cao C, Clifton DA, Cheng MP, Papenburg J, Buckeridge D, Bobrovitz N, Arora RK, Van Kerkhove MD, Unity Studies Collaborator Group. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. PLOS Medicine. 2022. DOI: 10.1371/journal.pmed.1004107.

Donnici C, Ilincic C, Cao C, Zhang C, Deveaux G, Clifton D, Buckeridge D, Bobrovitz N, Arora RK. Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance. Epidemics. Dec 2022. DOI: 10.1016/j.epidem.2022.100645.

Macdonald LK, Glogauer M, Allison P, Quiñonez C, Madathil S, Rock LD. Canadian dental hygienists’ experiences and perceptions of regulatory guidelines during the COVID-19 pandemic: a qualitative descriptive analysis. BMC Health Serv Res. 2022, 1570 2022 Dec 22;22(1570). doi: https://doi.org/10.1186/s12913-022-08925-z.

Brooks SC, Rosychuk RJ, Perry JJ, Morrison LJ, Wiemer H, Fok P, Rowe BH, Daoust R, Vatanpour S, Turner J, Landes M, Ohle R, Hayward J, Scheuermeyer F, Welsford M, Hohl C, the Canadian COVID-19 Rapid Response Network (CCEDRRN) for the Network of Canadian Emergency Researchers (NCER) and the Canadian Critical Care Trials Group (CCCTG). Derivation and validation of a clinical decision rule to risk-stratify COVID-19 patients discharged from the emergency department: The CCEDRRN COVID discharge score. JACEP Open. 2022; 3:e12868. doi: https://doi.org/10.1002/emp2.12868.

Costiniuk CT, Singer J, Lee T, Langlois MA, Arnold C, Galipeau Y, Needham J, Kulic I, Jenabian MA, Burchell AN, Shamji H, Chambers C, Walmsley S, Ostrowski M, Kovacs C, Tan DHS, Harris M, Hull M, Brumme ZL, Lapointe HR, Brockman MA, Margolese S, Mandarino E, Samarani S, Vulesevic B, Lebouché B, Angel JB, Routy JP, Cooper CL, Anis AH; COVAXHIV Study Group. COVID-19 vaccine immunogenicity in people with HIV. AIDS. 2023 Jan 1;37(1):F1-F10. doi: 10.1097/QAD.0000000000003429.

Maltseva M, Galipeau Y, Renner TM, Deschatelets L, Durocher Y, Akache B, Langlois MA. Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice. Vaccines. Dec 2022. DOI: 10.3390/vaccines11010030.

Healey GR, Golding L, Schick A, Majdoubi A, Lavoie PM, Vallance BA. Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination. Gut. Dec 2022. DOI: 10.1136/gutjnl-2022-328556.

O’Brien S, Caffrey N, Yi Q-L, Bolotin S, Janjua NZ, Binka M, Quach Thanh C, Stein D, Lang A, Colquhoun A, Pambrun C, Reedman C, Drews SJ. Cross-Canada variability in blood donor SARS-CoV-2 seroprevalence by social determinants of health, Microbiology Spectrum, 10 January 2023, DOI: https://doi.org/10.1128/spectrum.03356-22.

McEvoy CM, Hu Q, Abe KT, Yau K, Oliver MJ, Levin A, Gingras AC, Hladunewich MA, Yuen DA. Humoral Responses in the Omicron Era Following 3-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients. Transplant Direct. 2022 Dec 7;9(1):e1401. doi: 10.1097/TXD.0000000000001401. PMID: 36518793; PMCID: PMC9742098.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Speckmaier S, Barad E, Moran-Garcia M, Datwani S, Duncan MC, Kalikawe R, Ennis S, Young L, Ganase B, Omondi FH, Umviligihozo G, Dong W, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, DeMarco ML, Simons J, Hedgcock M, Prystajecky N, Lowe CF, Romney MG, Barrios R, Guillemi S, Brumme CJ, Montaner JSG, Hull M, Harris M, Niikura M, Brockman MA, Brumme ZL. Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART. AIDS:10.1097/QAD.0000000000003469, December 23, 2022. | DOI: 10.1097/QAD.0000000000003469.

Demone J, Maltseva M, Nourimand M, Nasr-Sharif M, Galipeau Y, Alarcon EI, Langlois MA, MacLean AM. Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines. PLoS One. 2022 Dec 14;17(12):e0277668. doi: 10.1371/journal.pone.0277668. PMID: 36516116; PMCID: PMC9749978. https://pubmed.ncbi.nlm.nih.gov/36516116/.

Park H, Linthwaite B, Dussault C, Halavrezos A, Chalifoux S, Sherman J, Del Balso L, Buxton JA, Cox J, Kronfli N. Factors associated with changes in illicit opioid use during the COVID-19 pandemic among incarcerated people who use drugs in Quebec, Canada. Int J Prison Health. 2022 Dec 19. doi: https://doi.org/10.1108/IJPH-06-2022-0038.

Walmsley S, Ravindran R, Clarke R, Wouters B, Silva A, Gingras A-C, Szadkowski L. COVID-19 breakthrough infections in vaccinated participants of the Safety and Efficacy of Preventative COVID Vaccines sub-study. Can J Infect Dis Med Microbiol. 2022 Dec. doi: https://doi.org/10.3138/jammi-2022-0011.

Fowokan, H. Samji, J. Puyat, N. Janjua, J. Wilton, J. Wong, T. Grennan, C. Chambers, A. Kroch, C. T. Costiniuk, C. L. Cooper, A. N. Burchell, A. Anis. Effectiveness of COVID 19 Vaccines in People Living with HIV in British Columbia and comparisons with a matched HIV-Negative Cohort: A Test Negative Design. International Journal of Infectious Diseases. 2022;194(45):E1529-E1536. DOI: 10.1016/j.ijid.2022.11.035.

Round 4: Preliminary Results, ENCORE – Children and COVID-19 Montreal seroprevalence study (May – September 2022).

Naveed Z, Li J, Spencer M, Wilton J, Naus M, García HAV, Otterstatter M, Janjua NZ. Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study. CMAJ. 2022;194(45):E1529-E1536. DOI: https://www.cmaj.ca/content/194/45/E1529.

Naveed Z, Li J, Wilton J, Spencer M, Naus M, Velásquez García HA, Kwong JC, Rose C, Otterstatter M, Janjua NZ; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines. J Am Coll Cardiol. 2022 Nov 15;80(20):1900–8, DOI: https://doi.org/10.1016/j.jacc.2022.08.799.

Paramo M. V., Abu-Raya B., Reicherz F., Xu R. Y., Bone J. N., Srigley J. A., Solimano A., Goldfarb D. M., Skowronski D. M., Lavoie P. M. Comparative analysis of pediatric Respiratory Syncytial Virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada. medRxiv. 2022. DOI: 10.1101/2022.11.18.22282477.

Kronfli N, Dussault C, Maheu-Giroux, M, Halavrezos A, Chalifoux S, Park H, Del Balso L, Cheng MP, Cox J. Importance of occupation for SARS-CoV-2 seroprevalence and COVID-19 vaccination among correctional workers in Quebec, Canada: A cross-sectional study. Front. Public Health, 09 November 2022. DOI: https://doi.org/10.3389/fpubh.2022.1021871.

Results from COVID-19 Vaccination During Pregnancy in Ontario, Report 6, posted at https://www.bornontario.ca/en/whats-happening/resources/Documents/COVID-19-Vaccination-during-pregnancy-in-Ontario_Report6.pdf.

Germain M, Lewin A, Bazin R, Dieudé M, Perreault J, Boivin A, Grégoire Y, Renaud C. Cohort profile: A Quebec-based plasma donor biobank to study COVID-19 immunity (PlasCoV). medRxiv. 2022 Nov 11. doi: https://doi.org/10.1101/2022.11.09.22282156.

Butler-Laporte G, Povysil G, Kosmicki JA, Cirulli ET, Drivas T, Furini S, Saad C, Schmidt A, Olszewski P, Korotko U, Quinodoz M, Çelik E, Kundu K, Walter K, Jung J, Stockwell AD, Sloofman LG, Jordan DM, Thompson RC, Del Valle D, Simons N, Cheng E, Sebra R, Schadt EE, Kim-Schulze S, Gnjatic S, Merad M, Buxbaum JD, Beckmann ND, Charney AW, Przychodzen B, Chang T, Pottinger TD, Shang N, Brand F, Fava F, Mari F, Chwialkowska K, Niemira M, Pula S, Baillie JK, Stuckey A, Salas A, Bello X, Pardo-Seco J, Gómez-Carballa A, Rivero-Calle I, Martinón-Torres F, Ganna A, Karczewski KJ, Veerapen K, Bourgey M, Bourque G, Eveleigh RJ, Forgetta V, Morrison D, Langlais D, Lathrop M, Mooser V, Nakanishi T, Frithiof R, Hultström M, Lipcsey M, Marincevic-Zuniga Y, Nordlund J, Schiabor Barrett KM, Lee W, Bolze A, White S, Riffle S, Tanudjaja F, Sandoval E, Neveux I, Dabe S, Casadei N, Motameny S, Alaamery M, Massadeh S, Aljawini N, Almutairi MS, Arabi YM, Alqahtani SA, Al Harthi FS, Almutairi A, Alqubaishi F, Alotaibi S, Binowayn A, Alsolm EA, El Bardisy H, Fawzy M, Cai F, Soranzo N, Butterworth A; COVID-19 Host Genetics Initiative; DeCOI Host Genetics Group; GEN-COVID Multicenter Study (Italy); Mount Sinai Clinical Intelligence Center; GEN-COVID consortium (Spain); GenOMICC Consortium; Japan COVID-19 Task Force; Regeneron Genetics Center, Geschwind DH, Arteaga S, Stephens A, Butte MJ, Boutros PC, Yamaguchi TN, Tao S, Eng S, Sanders T, Tung PJ, Broudy ME, Pan Y, Gonzalez A, Chavan N, Johnson R, Pasaniuc B, Yaspan B, Smieszek S, Rivolta C, Bibert S, Bochud PY, Dabrowski M, Zawadzki P, Sypniewski M, Kaja E, Chariyavilaskul P, Nilaratanakul V, Hirankarn N, Shotelersuk V, Pongpanich M, Phokaew C, Chetruengchai W, Tokunaga K, Sugiyama M, Kawai Y, Hasegawa T, Naito T, Namkoong H, Edahiro R, Kimura A, Ogawa S, Kanai T, Fukunaga K, Okada Y, Imoto S, Miyano S, Mangul S, Abedalthagafi MS, Zeberg H, Grzymski JJ, Washington NL, Ossowski S, Ludwig KU, Schulte EC, Riess O, Moniuszko M, Kwasniewski M, Mbarek H, Ismail SI, Verma A, Goldstein DB, Kiryluk K, Renieri A, Ferreira MAR, Richards JB. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative. PLoS Genet. 2022 Nov 3;18(11):e1010367. doi: 10.1371/journal.pgen.1010367.

Daroya E, Greya C, Lessard D, Klassen B, Skakoon-Sparling S, Gaspar M, Perez-Brumer A, Adam B, Lachowsky NJ, Moore D, Sang JM, Lambert G, Hart TA, Cox J, Jollimore J, Tan DHS, Grace D. ‘I did not have sex outside of our bubble’: Changes in Sexual Practices and Risk Reduction Strategies among Sexual Minority Men in Canada during the COVID-19 Pandemic. Culture, Health, and Sexuality. 2022 November. DOI: 10.1080/13691058.2022.2139414.

Windsor JW, Caplan L, Ingram RJM, Charlton C, Kanji JN, Tipples G, Holodinsky JK, Bernstein CN, Mahoney DJ, Bernatsky S, Benchimol EI, Kaplan GG; STOP COVID-19 in IBD Research Group. Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2022 Oct 25:S2468-1253(22)00340-5. DOI: 10.1016/S2468-1253(22)00340-5.

Tauzin A, Gong SY, Chatterjee D, Ding S, Painter MM, Goel RR, Beaudoin-Bussières G, Marchitto L, Boutin M, Laumaea A, Okeny J, Gendron-Lepage G, Bourassa C, Medjahed H, Goyette G, Williams JC, Bo Y, Gokool L, Morrisseau C, Arlotto P, Bazin R, Fafard J, Tremblay C, Kaufmann DE, De Serres G, Richard J, Côté M, Duerr R, Martel-Laferrière V, Greenplate AR, Wherry EJ, Finzi A. A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses. Cell Rep. 2022 Oct 25;41(4):111554. doi: 10.1016/j.celrep.2022.111554.

Zinszer K, Charland K, Pierce L, Saucier A, McKinnon B, Hamelin M-E, Cheriet I, Da Torre MB, Carbonneau J, Nguyen CT, De Serres G, Papenburg J, Boivin G, Quach C. Seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and adolescents in Montreal, Canada. medRxiv 2022 Oct 10. doi: https://doi.org/10.1101/2022.10.28.22281660.

Ma H., Chan A. K. Baral S. D, Fahim C., Straus S., Sander B., Mishra S. Which curve are we flattening? The disproportionate impact of COVID-19 among economically marginalized communities in Ontario, Canada, was unchanged from wild-type to omicron. medRxiv. 2022. DOI: 10.24.22281104.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Speckmaier S, Barad E, Moran-Garcia M, Datwani S, Duncan MC, Kalikawe R, Ennis S, Young L, Ganase B, Omondi FH, Umviligihozo G, Dong W, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, DeMarco ML, Simons J, Hedgcock M, Prystajecky N, Lowe CF, Romney MG, Barrios R, Guillemi S, Brumme CJ, Montaner JSG, Hull M, Harris M, Niikura M, Brockman MA, Brumme ZL. Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART. medRxiv. 2022. 11.03.22281912; DOI: https://doi.org/10.1101/2022.11.03.22281912.

Nantel S, Bourdin B, Adams K, Carbonneau J, Rabezanahary H, Hamelin M-E, McCormack D, Savard P, Longtin Y, Cheng MP, De Serres G, Corbeil J, Gilca V, Baz M, Boivin G, Quach C, Decaluwe H. Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination 1 influences the immunogenicity of BNT162b2 COVID-19 mRNA vaccine. Front Immunol. 2022 Oct 14;13:930252. doi: 10.3389/fimmu.2022.930252.

Bettinger JA, Irvine MA, Shulha HP, Valiquette L, Muller MP, Vanderkooi OG, Kellner JD, Top KA, Sadarangani M, McGeer A, Isenor JE, Marty K, Soe P, De Serres G; Canadian Immunization Research Network. Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network. Clin Infect Dis. 2022 Oct 31:ciac852. doi: 10.1093/cid/ciac852.

Holder KA, Ings DP, Harnum DOA, Russell RS, Grant MD. Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection. NPJ Vaccines. 2022 Oct 21;7(1):122. DOI: 10.1038/s41541-022-00546-1.

Sujane Kandasamy, Baanu Manoharan, Zainab Khan, Rosain Stennett, Dipika Desai, Rochelle Nocos, Gita Wahi, Davina Banner, Russell J de Souza, Scott Lear, Sonia S Anand. Perceptions of COVID-19 risk, vaccine access, and confidence: a qualitative analysis of South Asians in Canada. medRxiv 2022.10.21.22281321; doi: https://doi.org/10.1101/2022.10.21.22281321.

O’Brien SF, Caffrey N, Yi Q-L, Pambrun C, Drews SJ. SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron. Viruses. 2022; 14(11):2336. doi: https://doi.org/10.3390/v14112336.

Azeez R, Lotoski L, Dubeau A, Rodriguez N, Reyna ME, Freitas T, Goguen S, Medeleanu M, Winsor GL, Brinkman FSL, Cameron EE, Roos L, Simons E, Moraes TJ, Mandhane PJ, Turvey SE, Bolotin S, Wright K, McNeil D, Patrick DM, Bullard J, Langlois MA, Arnold CR, Galipeau Y, Pelchat M, Doucas N, Subbarao P, Azad MB. Investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort: study methodology and cohort profile. medRxiv. 2022 Oct 21. doi: https://doi.org/10.1101/2022.10.19.22281242

Chambers C, Samji H, Cooper CL, Costiniuk CT, Janjua NZ, Kroch AE, Arbess G, Benoit AC, Buchan SA, Chung H, Kendall CE, Kwong JC, Langlois MA, Lee SM, Mbuagbaw L, Mccullagh J, Moineddin R, Nambiar D, Walmsley S, Anis A, Burchell AN; COVAXHIV Study Team. COVID-19 Vaccine Effectiveness among a Population-based Cohort of People Living with HIV. AIDS. 2022 Oct 19. doi: 10.1097/QAD.0000000000003405.

Kimura M, Ferreira VH, Kothari S, Pasic I, Mattsson JI, Kulasingam V, Humar A, Mah A, Delisle JS, Ierullo M, Majchrzak-Kita B, Kumar D, Hosseini-Moghaddam SM. Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients. Transplant Cell Therapy. 2022 Oct;28(10): 706.e1-706.e10. doi: 10.1016/j.jtct.2022.07.024.

Ma X, Li Z, Whelan M, Kim D, Cao C, Yanes-Lane M, Yan T, Jaenisch T, Chu M, Clifton DA, Subissi L, Bobrovitz N, Arora RK. Serology assays used in SARS-CoV-2 seroprevalence surveys worldwide: a systematic review and meta-analysis of assay features, testing algorithms, and performance. medRxiv. 2022 Oct 15. doi: doi.org/10.1101/2022.10.13.22280957.

Cable J, Fauci A, Dowling WE, Günther S, Bente DA, Yadav PD, Madoff LC, Wang LF, Arora RK, Van Kerkhove M, Chu MC, Jaenisch T, Epstein JH, Frost SDW, Bausch DG, Hensley LE, Bergeron É, Sitaras I, Gunn MD, Geisbert TW, Muñoz-Fontela C, Krammer F, de Wit E, Nordenfelt P, Saphire EO, Gilbert SC, Corbett KS, Branco LM, Baize S, van Doremalen N, Krieger MA, Clemens SAC, Hesselink R, Hartman D. Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report. Annals of the New York Academy of Sciences. 2022. Doi: 10.1111/nyas.14898.

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes. JAMA Network Open. 2022 Sep 22. doi: https://doi.org/10.1001/jamanetworkopen.2022.32760.

Asamoah-Boaheng M., Goldfarb D. M., Karim M. E., O’Brien S. F., Wall N., Drews S. J., Barakauskas J., Jassem A. N., Grunau B. The relationship between anti-spike SARS-CoV-2 antibody levels and risk of breakthrough COVID-19 among fully vaccinated adults. The Journal of Infectious Diseases. 2022. Doi: 10.1093/infdis/jiac403.

Chung H, Austin PC, Brown KA, Buchan SA, Fell DB, Fong C, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study. Open Forum Infect Dis. 2022 Sep 7;9(9):ofac449. DOI: https://doi.org/10.1093/ofid/ofac449.

Ma H, Yiu KC, Baral SD, Fahim C, Moloney G, Darvin D, Landsman D, Chan AK, Straus S, Mishra S. COVID-19 cases among congregate care facility staff by neighbourhood of residence and social and structural determinants: observational study. JMIR Public Health and Surveillance. 2022 Jul 21. doi: https://doi.org/10.2196/34927.

Mwimanzi FM, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Kalikawe R, Datwani S, Burns L, Young L, Leung V, Ennis S, Brumme CJ, Montaner JSG, Prystajecky N, Lowe CF, DeMarco ML, Holmes DT, Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA.  Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine. medRxiv, 2022.08.08.22278494; doi: https://doi.org/10.1101/2022.08.08.22278494.

Breznik JA, Huynh A, Zhang A, Bilaver L, Bhakta H, Stacey HD, Ang JC, Bramson JL, Nazy I, Miller MS, Denburg J, Costa AP, Bowdish DME, other members of the COVID-in-LTC Investigator Group. Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination. Journal of Immunology, September 28, 2022, ji2200369; DOI: https://doi.org/10.4049/jimmunol.2200369

Butler-Laporte G, Gonzalez-Kozlova E, Su CY, Zhou S, Nakanishi T, Brunet-Ratnasingham E, Morrison D, Laurent L, Afilalo J, Afilalo M, Henry D, Chen Y, Carrasco-Zanini J, Farjoun Y, Pietzner M, Kimchi N, Afrasiabi Z, Rezk N, Bouab M, Petitjean L, Guzman C, Xue X, Tselios C, Vulesevic B, Adeleye O, Abdullah T, Almamlouk N, Moussa Y, DeLuca C, Duggan N, Schurr E, Brassard N, Durand M, Del Valle DM, Thompson R, Cedillo MA, Schadt E, Nie K, Simons NW, Mouskas K, Zaki N, Patel M, Xie H, Harris J, Marvin R, Cheng E, Tuballes K, Argueta K, Scott I; Mount Sinai COVID-19 Biobank Team, Greenwood CMT, Paterson C, Hinterberg M, Langenberg C, Forgetta V, Mooser V, Marron T, Beckmann N, Kenigsberg E, Charney AW, Kim-Schulze S, Merad M, Kaufmann DE, Gnjatic S, Richards JB. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals. Clin Proteomics. 2022 Sep 28. Doi: https://doi.org/10.1186/s12014-022-09371-z.

Grunau B, Prusinkiewicz M, Asamoah-Boaheng M, Golding L, Lavoie PM, Petric M, Levett PN,   Haig S, Barakauskas V, Karim ME, Jassem AN, Drews SJ,  Sediqi S, Goldfarb DM. Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals. Microbiol Spectr. 2022 Sep 19;0(0):e01315-22 DOI: https://doi.org/10.1128/spectrum.01315-22.

Pluss O., Campbell H., Pezzi L., Morales I., Roell Y., Quandelacy T. M., Arora R. H., Boucher E., Lamb M. M., Chu M., Bärnighausen T., Jaenisch T. Limitations introduced by a low participation rate of SARS-CoV-2 seroprevalence data. International Journal of Epidemiology (2022). doi: https://doi.org/10.1093/ije/dyac178.

Steinberg N., Allison P. and Levin L. Infection Prevention Strategies Concordance in Canadian Dental Schools During the COVID-19 Pandemic. International Dental Journal (2022). doi: 10.1016/j.identj.2022.07.005.

Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R,  Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Yi QL, O’Brien SF, Drews SJ. Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses. Microbiology Spectrum. 0(0):e02811-22. doi: https://doi.org/10.1128/spectrum.02811-22

Akingbola S., Fernandes R., Borden S., Gilbride K., Oswald C., Straus S., Tehrani A., Thomas J., Stuart R. Early identification of a COVID-19 outbreak detected by wastewater surveillance at a large homeless shelter in Toronto, Ontario. Canadian Journal of Public Health. (2022). doi: 10.17269/s41997-022-00696-8.

Fu, Z.; Rais, Y.; Dara, D.; Jackson, D.; Drabovich A.P. Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted Proteomics. Analytical Chemistry 2022, Epub September 12; doi: https://doi.org/10.1021/acs.analchem.2c01325.

Burrows AG, Linton S, Thiele J, Sheth PM, Evans GA, Archer S, Doliszny KM, Finlayson M, Flynn L, Gong Y, Huang Y, Kasmani A, Moore K, Sanfilippo A, Snelgrove-Clarke E, Tripp DA, Walker DMC, Vanner S, Ellis AK, Asymptomatic Surveillance Testing for COVID-19 in Health Care Professional Students: Lessons learned from a low prevalence setting. 11 avril 2022, Research Square, Doi: https://doi.org/10.21203/rs.3.rs-1505764/v1.

Lewis HC, Ware H, Whelan M, Subissi L, Li Z, Ma X, Nardone A, Valenciano M, Cheng B, Noel K, Cao C, Yanes-Lane M, Herring BL, Talisuna A, Ngoy N, Balde T, Clifton D, Van Kerkhove MD, Buckeridge D, Bobrovitz N, Okeibunor J, Arora RK, Bergeri I; UNITY Studies Collaborator Group. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Glob Health. 2022 Aug;7(8):e008793. doi: 10.1136/bmjgh-2022-008793.

Atiquzzaman M, Zheng Y, Er L, Djurdjev O, Singer J, Krajden M, Balamchi S, Thomas D, Oliver MJ, Levin A. COVID-19 vaccine effectiveness in patients with non-dialysis dependent chronic kidney diseases; findings from a population-based observational study from British Columbia, Canada. Kidney international. 2022 Sep 11. Doi:  https://doi.org/10.1016/j.kint.2022.08.027.

Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, Zhang K, Patel Z, Salter B, Yuen ACY, Soon K, -Lau K, Cowbrough B, Radford K, Huang C, Kjarsgaard M, Dvorkin-Gheva A, Smith J, Li QZ, Waserman S, Ryerson CJ, Nair P, Ho T, Balakrishnan N, Nazy I, Bowdish DME, Svenningsen S, Carlsten C, Mukherjee M. Circulating Antinuclear Autoantibodies in COVID-19 Survivors Predict Long-COVID Symptoms. European Respiratory Journal, 2022, 2200970; DOI: 10.1183/13993003.00970-2022.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Kalikawe R, Datwani S, Waterworth R, Umviligihozo G, Ennis S, Young L, Dong W, Kirkby D, Burns L, Leung V, Holmes D, DeMarco DL, Simons J, Matic N, Montaner JSG, Brumme CJ, Prystajecky N, Niikura M, Lowe CF, Romney MG, Brockman MA, Brumme ZL. Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination. Front. Immunol. 2022 September 6. Doi: 10.3389/fimmu.2022.947021.

Nasreen S, Febriani Y, Velásquez García HA, Zhang G, Tadrous M, Buchan SA, Righolt CH, Mahmud SM, Janjua NZ, Krajden M, De Serres G, Kwong JC, Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study, Clinical Infectious Diseases, 2022; ciac634, https://doi.org/10.1093/cid/ciac634.

Jenkinson JIR, Sniderman R, Gogosis E, Liu M, Nisenbaum R, Pedersen C, Spandier O, Tibebu T, Dyer A, Crichlow F, Richard L, Orkin A, Thulien N, Kiran T, Kayseas J, Hwang SW. Exploring COVID-19 vaccine uptake, confidence and hesitancy among people  experiencing homelessness  in Toronto, Canada: protocol  for the Ku-gaa-gii pimitizi-win qualitative study. BMJ Open. 2022 17 août. Doi: 10.1136/bmjopen-2022-06422.

Bazin R, Rochette S, Perreault J, Fournier M-J, Grégoire Y, Boivin A, Lewin A, Germain M, Renaud C. Development and use of a method based on the anti-N reactivity of longitudinal 1 samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population. medRxiv 2022.08.15.22278798; doi: https://doi.org/10.1101/2022.08.15.22278798.

Mwimanzi FM, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Kalikawe R, Datwani S, Burns L, Young L, Leung V, Ennis S, Brumme CJ, Montaner JSG, Prystajecky N, Lowe CF, DeMarco ML, Holmes DT, Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA. Brief Report: Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine. medRxiv, 2022.08.08.22278494; doi: https://doi.org/10.1101/2022.08.08.22278494.

Fell DB, Dimanlig-Cruz S, Regan AK, Håberg SE, Gravel CA, Oakley L, Alton GD, Török E, Dhinsa T, Shah PS, Wilson K, Sprague AE, El-Chaâr D, Walker MC, Barrett J, Okun N, Buchan SA, Kwong JC, Wilson SE, Dunn SI, MacDonald SE, Dougan SD, Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study. BMJ 2022; 378 :e071416.  Doi: 10.1136/ bmj-2022-071416.

Sadarangani M, Soe P, Shulha HP, Valiquette L, Vanderkooi OG, Kellner JD, Muller MP, Top KA, Isenor JE, McGeer A, Irvine M, De Serres G, Marty K, Bettinger JA; Canadian Immunization Research Network. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. Lancet Infect Dis. 2022 Aug 11:S1473-3099(22)00426-1. doi: 10.1016/S1473-3099(22)00426-1.

Ferreira VH, Solera JT, Hu Q, Hall VG, Arbol BG, Rod Hardy W, Samson R, Marinelli T, Ierullo M, Virk AK, Kurtesi A, Mavandadnejad F, Majchrzak-Kita B, Kulasingam V, Gingras AC, Kumar D, Humar A. Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings. Nat Commun. 2022 Aug 4;13(1):4489. doi: 10.1038/s41467-022-32235-x.

Richard L, Liu M, Jenkinson J, Nisenbaum R, Brown M, Pedersen C, Hwang S. COVID-19 vaccine coverage and sociodemographic, behavioural and housing factors associated with vaccination among people experiencing homelessness in Toronto, Canada: A cross-sectional study. Vaccines. 3 août 2022. doi: https://doi.org/10.3390/vaccines10081245.

Richard L, Nisenbaum R, Liu M, McGeer A, Mishra S, Gingras A-C, Gommerman JL, Sniderman R, Pedersen C, Spandier O, Jenkinson JIR, Baral S, Mejia-Lancheros C, Agarwal A, Jamal AJ, Ostrowski M, Dhalla I, Stewart S, Gabriel M, Brown M, Hester J, Hwang SW. Ku-gaa-gii pimitizi-win, the COVID-19 cohort study of people experiencing homelessness in Toronto, Canada: a study protocol. BMJ Open. 27 juin 2022. doi: https://bmjopen.bmj.com/content/12/8/e063234

Parham KA, Kim GN, Saeedian N, Ninkov M, Richer CG, Li Y, Wu K, Rashu R, Barr SD, Arts EJ, Haeryfar S.MM, Kang CY, Troyer RM. Monovalent and trivalent VSV-based COVID-19 vaccines elicit potent neutralizing antibodies and immunodominant CD8+ T cells against diverse SARS-CoV-2 variants. bioRxiv 2022.07.19.500626; doi: https://doi.org/10.1101/2022.07.19.500626.

Grunau B, Tom J, Asamoah-Boaheng M, O’Brien SF, Drews SJ, Sediqi S, Lavoie PM, Barakauskas V, Goldfarb DM, Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections, Open Forum Infectious Diseases, 2022, ofac349, https://doi.org/10.1093/ofid/ofac349.

Choi A, Mâsse L.C., Bardwell S, Zhao Y, Xu YXZ, Markarian A, Coombs D, Watts A, Macdonald A, Dhillon N, Irvine M O’Reilly C, Lavoie PM, Goldfarb D. Symptomatic and asymptomatic transmission of SARS-CoV-2 in K-12 schools, British Columbia, April to June 2021. Microbiology Spectrum. 6 juillet 2022. DOI: https://doi.org/10.1128/spectrum.00622-22.

Watts AW, Mâsse LC, Goldfarb DM, Irvine MA, Hutchison SE, Muttucomaroe L, Poon B, Barakauskas VE, O’Reilly C, Bosman ES, Reicherz F, Coombs D, Pitblado M, O’Brien SF, Lavoie PM. SARS-CoV-2 seroprevalence among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada. medRxiv 2022.07.04.22277230; doi: https://www.medrxiv.org/content/10.1101/2022.07.04.22277230v1.

Breznik JA, Rahim A, Kajaks T, Hagerman M, Bilaver L, Colwill K, Dayam RM, Gingras AC, Verschoor CP, McElhaney JE, Bramson JL, Bowdish DME, Costa AP. Protection from Omicron infection in residents of nursing and retirement homes in Ontario, Canada. medRxiv 2022.06.28.22277016; doi: https://www.medrxiv.org/content/10.1101/2022.06.28.22277016v1.

Grunau B, O’Brien SF, Kirkham TL, Helmer J, Demers PA, Asamoah-Boaheng M, Drews SJ, Karim ME, Srigley JA, Sediqi S, O’Neill D, Drennan IR, Goldfarb DM. A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic. Ann Emerg Med. 2022 Jul;80(1):38-45. doi: 10.1016/j.annemergmed.2022.03.009.

Anand SS, Arnold C, Bangdiwala S, Bolotin S, Bowdish D, Chanchlani R, de Souza R, Desai D, Kandasamy S, Khan F, Khan Z, Langlois M-A, Limbachia J, Lear S, Loeb M, Loh L, Manoharan B, Nakka K, Pelchat M,  Punthakee Z, Schulze K, Williams N, Wahi G. Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study. CMAJ Open juillet 5 2022. DOI:10.9778/cmajo.20220031.

Coope RJN, Matic N, Pandoh PK, Corbett RD, Smailus DE, Pleasance S, Lowe CF, Ritchie G, Chorlton SD, Young M, Ally AA, Asano JK, Carlsen RE, Chahal SS, Zhao Y, Holmes DT, Romney MG, Jones SJM, Marra MA. Automated Library Construction and Analysis for High-throughput Nanopore Sequencing of SARS-CoV-2. Journal of Applied Laboratory Medicine, 2022;, jfac054, https://doi.org/10.1093/jalm/jfac054.

Andrew MK, Godin J, LeBlanc J, Boivin G, Valiquette L, McGeer A, McElhaney JE, Hatchette TF, ElSherif M, MacKinnon-Cameron D, Wilson K, Ambrose A, Trottier S, Loeb M, Smith SW, Katz K, McCarthy A, McNeil SA. Older Age and Frailty are Associated with Higher Mortality but Lower ICU Admission with COVID-19. Can Geriatr J [Internet]. juin 2022. 1 [cited 2022 Jun. 17]; 25(2):183-96. Doi: https://doi.org/10.5770/cgj.25.546.

Ullah I, Beaudoin-Bussières G, Symmes K, Cloutier M, Ducas E, Tauzin A, Laumaea A, Bégin P, Mothes W, Kumar P, Bazin R, Finzi A, Uchil PD. The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice. bioRxiv 2022.06.10.495677; doi: https://doi.org/10.1101/2022.06.10.495677.

McEvoy CM, Hu Q, Abe KT, Yau K, Oliver MJ, Levin A, Gingras AC, Hladunewich MA, Yuen DA, Humoral Responses in the Omicron Era following Three-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients, medRxiv 2022.06.24.22276144; doi: https://doi.org/10.1101/2022.06.24.22276144.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Speckmaier S, Moran-Garcia N, Datwani S, Duncan MC, Agafitei O, Ennis S, Young L, Ali H, Ganase B, Omondi FH, Dong W, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis A, Leung V, Holmes DT, DeMarco ML, Simons J, Hedgcock M, Prystajecky N, Lowe CF, Pantophlet R, Romney MG, Barrios R, Guillemi S, Brumme CJ, Montaner JSG, Hull M, Harris M, Niikura M, Brockman MA, Brumme ZL. People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.  The Journal of Infectious Diseases, 2022; jiac229, https://doi.org/10.1093/infdis/jiac229.

Oliver MJ, Blake PG. Clinical Utility of COVID-19 Vaccination in Patients Undergoing Hemodialysis. Clin J Am Soc Nephrol. 1 juin 2022;17(6):779–81. https://doi.org/10.2215/CJN.04930422.

Kanji JN, Nguyen LT, Plitt SS, Charlton CL, Fenton J, Braun S, Marohn C, Lau C, Svenson LW, Hinshaw D, Lutsiak C, Zelyas N, Mengel M, Tipples G. Seropositivity to SARS-CoV-2 in Alberta, Canada in a post-vaccination period (March 2021–July 2021). Infectious Diseases. 31 mai 2022. DOI: 10.1080/23744235.2022.2080250.

Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE, Kwong JC. Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance. Vaccine. 26 mai 2022. doi:  10.1016/j.vaccine.2022.04.065.

Breznik JA, Huynh A, Zhang A, Bilaver L, Bhakta H, Stacey HD, Ang JC, Bramson JL, Nazy I, Miller MS, Denburg J, Costa AP, Bowdish DME, other members of the COVID-in-LTC Investigator Group. CMV seropositivity in older adults changes T cell functionality, but does not prevent antibody or cellular SARS-CoV-2 vaccine responses. medRxiv. 28 mai 2022. Doi: 10.1101/2022.05.27.22275673.

Quan J, Ma C, Panaccione R, Hracs L, Sharifi N, Herauf M, Makovinović A, Coward S, Windsor JW, Caplan L, Ingram RJ. Kanji JN, Tipples G, Holodinsky JK, Bernstein CN, Mahoney DJ, Bernatsky S, Benchimol EI, Kaplan GG, STOP COVID-19 in IBD Research Group. Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease. Gut. 23 mai 2022. Doi: 10.1136/gutjnl-2022-327440.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Kalikawe R, Datwani S, Waterworth R, Umviligihozo G, Ennis S, Young L, Dong W, Kirkby D, Burns L, Leung V, Holmes D, DeMarco DL, Simons J, Matic N, Montaner JSG, Brumme CJ, Prystajecky N, Niikura M, Lowe CF, Romney MG, Brockman MA, Brumme ZL. Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination. medRxiv. 21 mai 2022. Doi: 10.1101/2022.05.19.22275026

Brown PE, Fu SH, Bansal A, Newcombe L, Colwill K, Mailhot G, Delgado-Brand M, Gingras AC, Slutsky AS, Pasic M, Companion J, Bogoch II, Morawski E, Lam T, Reid A, Jha P. Ab‑C Study Collaborators. Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults. N Engl J Med. Le 18 mai 2022. doi : 10.1056/NEJMc2202879.

Bhatt M, Zemek RL, Tang K, Malley R, Plint AC, Pham-Huy A, Dawson J, McGahern C, Pelchat M, Arnold C, Galipeau Y, Langlois MA. Antibody Seronegativity in COVID-19 RT-PCR-Positive Children. Pediatr Infect Dis J. Le 9 mai 2022. doi : 10.1097/INF.0000000000003573.

Matic N, Lowe CF, Ritchie G, Young M, Lawson T, Romney MG. Omicron (B. 1.1. 529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other Variants of Concern and impact on diagnostic testing strategy. Clin Microbiol Infect. Le 11 mai 2022. doi : https://doi.org/10.1016/j.cmi.2022.04.022.

Yoo S, Garg E, Elliott LT, Hung RJ, Halevy AR, Brooks JD, Bull SB, Gagnon F, Greenwood CM, Lawless JF, Paterson AD, Sun L, Zawati MH, Lerner-Ellis J, Abraham RJS, Birol I, Bourque G, Garant J-M, Gosselin C, Li J, Whitney J, Thiruvahindrapuram B, Herbrick J-A, Lorenti M, Reuter MS, Liu S, Allen U, Bernier FP, Biggs CM, Cheung AM, Cowan J, Herridge M, Maslove DM, Modi BP, Mooser V, Morris SK, Ostrowski M, Parekh RS, Pfeffer G, Suchowersky O, Taher J, Turvey SE, Upton J, Warren RL, Yeung RSM, Aziz N, Knoppers BM, Lathrop M, Jones SJM, Scherer SW, Strug LJ. HostSeq: A Canadian Whole Genome Sequencing and Clinical Data Resource. medRxiv. Le 10 mai 2022. doi : 10.1101/2022.05.06.22274627.

McClymont E, Albert AY, Alton GD, Boucoiran I, Castillo E, Fell DB, Kuret V, Poliquin V, Reeve T, Scott H, Sprague AE, Carson G, Cassell K, Crane J, Elwood C, Joynt C, Murphy P, Murphy-Kaulbeck L, Saunders S, Shah P, Snelgrove JW, van Schalkwyk J, Yudin MH, Money D; CANCOVID-Preg Team. Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes. JAMA. Le 2 mai 2022. doi: 10.1001/jama.2022.5906.

Reicherz F, Xu RY, Abu-Raya B, Majdoubi A, Michalski C, Golding L, Stojic A, Vineta M, Granoski M, Cieslak Z, Chacko A, Desai N, Sekirov I, Marchant DJ, Lavoie PM. Waning immunity against respiratory syncytial virus during the COVID-19 pandemic. Journal of Infectious Diseases. Le 7 mai 2022. doi: org/10.1093/infdis/jiac192.

Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Datwani S, Omondi FH, Burns L, Young L, Leung V, Agafitei O, Ennis S, Dong W, Basra S, Lim LY, Ng K, Pantophlet R, Brumme CJ, Montaner JSG, Prystajecky N, Lowe CF, DeMarco ML, Holmes DT, Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA (2022). Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose. J Infect Dis; jiac199. doi: 10.1093/infdis/jiac199.

Racine É, Boivin G, Longtin Y, Mccormack D, Decaluwe H, Savard P, Cheng MP, Hamelin ME, Carbonneau J, Tadount F, Adams K, Bourdin B, Nantel S, Gilca V, Corbeil J, De Serres G, Quach-Thanh C. The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers. Influenza Other Respir Viruses; 2022; 1-10. doi: 10.1111/irv.12997

Widdifield J, Kwong JC, Chen S, Eder L, Benchimol EI, Kaplan GG, Hitchon C, Aviña-Zubieta JA, Lacaille D, Chung H, Bernatsky S. Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis. Lancet Rheumatol. Le 14 avril 2022. doi : 10.1016/S2665-9913(22)00096-0

Watts A.W., Hutchison S.M., Bettinger J.A., Gadermann A., Oberle E., Oberlander T.F., Goldfarb D.M., Lavoie P.M., Masse L.C. COVID-19 Vaccine Intentions and Perceptions Among Public School Staff of the Greater Vancouver Metropolitan Area, British Columbia, Canada. Front. Public Health, 27 avril 2022 https://doi.org/10.3389/fpubh.2022.832444

Reedman CN, Drews SJ, Yi QL, Pambrun C, O’Brien SF. Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era. Microbiology Spectrum. Le 12 avril 2022. doi : 10.1128/spectrum.00339-22

Bhatt M, Plint AC, Tang K, Malley R, Huy AP, McGahern C, Dawson J, Pelchat M, Dawson L, Varshney T, Arnold C, Galipeau Y, Austin M, Thampi N, Alnaji F, Langlois MA, Zemek RL. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study. CMAJ Open. Avril 2020;10(2):E357-66. doi : 10.9778/cmajo.20220026.

Nasreen S, Febriani Y, Velásquez García HA, Zhang G, Tadrous M, Buchan SA, Righolt CH, Mahmoud SM, Janjua NZ, Krajden M, De Serres G, Kwong JC. Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study. medRxiv. 2022.04.13.22273825; doi : https://doi.org/10.1101/2022.04.13.22273825

McMillan B, Marquez AC, Gaultier GN, Bartlett SR, Skowronski D, Levings M, Steiner T, Zlosnik J, Krajden M, Morshed M, Sekirov I, Jassem AN, Sadarangani M. Prospective Evaluation of Immunity After COVID-19 Vaccines: The PREVENT-COVID Study.

Banerjee A, Lew J, Kroeker A, Baid K, Aftanas P, Nirmalarajah K, Maguire F, Kozak R, McDonald R, Lang A, Gerdts V, Straus SE, Gilbert L, Li AX, Mozafarihasjin M, Walmsley S, Gingras AC, Wrana JL, Mazzulli T, Colwill K, McGeer AJ, Mubareka S, Falzarano D. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants. Med. Le 13 avril 2022. doi : 10.1016/j.medj.2022.04.002

Nantel S, Bourdin B, Adams K, Carbonneau J, Rabezanaha H, Hamelin ME, McCormack D, Savard P, Longtin Y, Cheng M, DeSerres G, Corbeil J, Gilca V, Baz M, Boivin G, Quach C, Decaluwe H. Immunogenicity of Pfizer-BioNTech COVID-19 mRNA Primary Vaccination Series in Recovered Individuals Depends on Symptoms at Initial Infection. medRxiv. Le 1^er janvier 2022. doi : 10.1101/2022.03.29.22272714.

Hutchison SM, Watts A, Gadermann A, Oberle E, Oberlander TF, Lavoie PM, Mâsse LC. School staff and teachers during the second year of COVID-19: Higher anxiety symptoms, higher psychological distress, and poorer mental health compared to the general population. J Affect Disord. Le 17 mars 2022. doi : 10.1016/j.jadr.2022.100335.

Anand SS, Arnold C, Bangdiwala S, Bolotin S, Bowdish D, Chanchlani R, de Souza R, Desai D, Kandasamy S, Khan F, Khan Z, Langlois M-A, Limbachia J, Lear S, Loeb M, Loh L, Manoharan B, Nakka K, Pelchat M, Punthakee Z, Schulze K, Williams N, Wahi G. What factors converged to create a COVID-19 hot-spot? Lessons from the South Asian community in Ontario. medRxiv. Le 1^er avril 2022. doi : 10.1101/2022.04.01.22273252.

Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Dhillon N, Irvine MA, Reicherz F, O’Reilly C, Sediqi S, Xu RY, Razzaghian HR, Sadarangani M, Coombs D, O’Brien SF, Lavoie PM. SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study. BMJ Open. Le 5 avril 2022. doi : 10.1136/bmjopen-2021-057846.

Jantzen R, Maltais M, Broët P. Socio-Demographic Factors Associated With COVID-19 Vaccine Hesitancy Among Middle-Aged Adults During the Quebec’s Vaccination Campaign. Front Public Health, le 18 mars 2022. https://doi.org/10.3389/fpubh.2022.756037

Fell DB, Dhinsa T, Alton GD, Török E, Dimanlig-Cruz S, Regan AK, Sprague AE, Buchan SA, Kwong JC, Wilson SE, Håberg SE, Gravel CA, Wilson K, El-Chaâr D, Walker MC, Barrett J, MacDonald SE, Okun N, Shah PS, Dougan SD, Dunn S, Bisnaire L. Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes. JAMA. Publié en ligne le 24 mars 2022. doi : 10.1001/jama.2022.4255.

Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Speckmaier S, Moran-Garcia N, Datwani S, Duncan MC, Agafitei O, Ennis S, Young L, Ali H, Ganase B, Omondi FH, Dong W, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis A, Leung V, Holmes DT, DeMarco ML, Simons J, Hedgcock M, Prystajecky N, Lowe CF, Pantophlet R, Romney MG, Barrios R, Guillemi S, Brumme CJ, Montaner JSG, Hull M, Harris M, Niikura M, Brockman MA, Brumme ZL. People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses. medRxiv. 2022.03.22.22272793; doi : https://doi.org/10.1101/2022.03.22.22272793.

Colwill K, Galipeau Y, Stuible M, Gervais C, Arnold C, Rathod B, Abe KT, Wang JH, Pasculescu A, Maltseva M, Rocheleau L, Pelchat M, Fazel-Zarandi M, Iskilova M, Barrios-Rodiles M, Bennett L, Yau K, Cholette F, Mesa C, Li AX, Paterson A, Hladunewich MA, Goodwin PJ, Wrana JL, Drews SJ, Mubareka S, McGeer AJ, Kim J, Langlois MA, Gingras AC, Durocher Y. A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. Clin Transl Immunol. Le 23 mars 2022. doi : 10.1002/cti2.1380.

Nikiforuk AM, McMillan B, Bartlett SR, Márquez AC, Pidduck T, Kustra J, Goldfarb DM, Barakauskas V, Sinclair G, Patrick DM, Sadarangani M, Ogilvie GS, Krajden M, Morshed M, Sekirov I, Jassem AN. Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response. Microbiol Spectr. Le 10 mars 2022:e0140521. doi : 10.1128/spectrum.01405-21.

Oliver MJ, Thomas D, Balamchi S, Ip J, Naylor K, Dixon SN, McArthur E, Kwong J, Perl J, Atiquzzaman M, Singer J, Yeung A, Hladunewich M, Yau K, Garg AX, Leis JA, Levin A, Krajden M, Blake PG. Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada. JASN Mars 2022, ASN.2021091262; doi : https://doi.org/10.1681/ASN.2021091262

Grunau B, Golding L, Prusinkiewicz MA, Asamoah-Boaheng M, Armour R, Citlali Marquez A, Jassem AN, Barakauskas V, O’Brien SF, Drews SJ, Haig S, Lavoie PM, Goldfarb DM. Comparative 6-month Wild-Type and Delta-Variant Antibody levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 vs. mRNA-1273. Microbiol Spectr Le 7 mars 2022:e0270221. doi: 10.1128/spectrum.02702-21.

Asamoah-Boaheng M, Goldfarb D, Prusinkiewicz M, Golding L, Karim M, Barakauskas V, Wall N, Jassem A, Marquez A, MacDonald C, O’Brien S, Lavoie P, Grunau B. Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity. bioRxiv 2022.03.01.482592; doi : https://doi.org/10.1101/2022.03.01.482592

Walmsley S, Szadkowski L, Wouters B, Clarke R, Colwill K, Rochon P, Brudno M, Ravindran R, Raboud J, McGeer A, Oza A. Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study. medRxiv. Le 10 février 2022. doi : 10.1101/2022.02.09.22270734v1

Tang X, Sharma A, Pasic M, Brown P, Colwill K, Gelband H, Birnboim HC, Nagelkerke N, Bogoch II, Bansal A, Newcombe L, Slater J, Rodriguez PS, Huang G, Fu SH, Meh C, Wu CN, Kaul R, Langlois MA, Morawski E, Hollander A, Eliopoulos D, Aloi B, Lam T, Abe KT, Rathod B, Fazel-Zarandi M, Wang J, Iskilova M, Pasculescu A, Caldwell L, Barrios-Rodiles M, Mohammed-Ali Z, Vas N, Santhanam DR, Cho ER, Qu K, Jha S, Jha V, Suraweera W, Malhotra V, Mastali K, Wen R, Sinha S, Reid A, Gingras AC, Chakraborty P, Slutsky AS, Jha P. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults. JAMA Network Open. Le 16 février 2022;5(2):e2146798. doi : 10.1001/jamanetworkopen.2021.46798.

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. Effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes. medRxiv 2021. doi : https://doi.org/10.1101/2021.12.30.21268565

Hall VG, Ferreira V, Ierullo M, Ku T, Majchrzak-Kita B, Kulasingam V, Humar A, Kumar D. Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses. Nat Immunol (2022). doi : https://doi.org/10.1038/s41590-021-01126-6

Yau K, Chan CT, Abe KT, Jiang Y, Atiquzzaman M, Mullin SI, Shadowitz E, Liu L, Kostadinovic E, Sukovic T, Gonzalez A, McGrath-Chong ME, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Levin A, Blake PG, Colwill K, Gingras AC et Hladunewich MA. Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis. CMAJ. Le 3 février 2022;cmaj.211881; DOI : https://doi.org/10.1503/cmaj.211881

Ings DP, Hatfield KM, Fifield KE, Harnum DOA, Holder KA, Russell RS, Grant MD. Few SARS-CoV-2 infections detected in Newfoundland and Labrador in the absence of Public Health Laboratory-based confirmation. PLoS One. Le 28 janvier 2022;17(1):e0262957. doi : 10.1371/journal.pone.0262957.

Dayam RM, Law JC, Goetgebuer RL, Chao GYC, Abe KT, Sutton M, Finkelstein N, Stempak JM, Pereira D, Croitoru D, Acheampong L, Rizwan S, Rymaszewski K, Milgrom R, Ganatra D, Batista NV, Girard M, Lau I, Law R, Cheung MW, Rathod B, Kitaygorodsky J, Samson R, Hu Q, Haroon N, Inman RD, Piguet V, Chandran V, Silverberg MS, Gingras AC, Watts TH. Antibody and T cell responses to SARS-CoV-2 mRNA vaccines during maintenance therapy for immune-mediated inflammatory diseases. medRxiv 2022.01.26.22269856; doi : https://doi.org/10.1101/2022.01.26.22269856

Widdifield J, Eder L, Chen S, Kwong JC, Hitchon C, Lacaille D, Aviña-Zubieta JA, Svenson LW, Bernatsky S. COVID-19 Vaccination Uptake among individuals with Immune-Mediated Inflammatory Diseases in Ontario, Canada between December 2020 and October 2021: A population-based analysis. J Rheumatol. Le 15 janvier 2022:jrheum.211148. doi : 10.3899/jrheum.211148.

Zhang A, Breznik JA, Clare R, Nazy I, Miller MS, Bowdish DME, Costa AP. Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents. J Am Med Dir Assoc. Le 15 janvier 2022:S1525-8610(21)01109-9. doi : 10.1016/j.jamda.2021.12.035.

Hall V, Ferreira V, Ierullo M, Ku T, Majchrzak-Kita B, Kulasingam V, Humar A, Kumar D. Delayed interval BNT162b2 mRNA COVID-19 vaccination provides robust immunity. 2021, Nature Immunology.

Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE, Kwong JC. Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance. medRxiv. Le 16 janvier 2022. doi : 10.1101/2022.01.12.22269169.

Banerjee A, Lew J, Kroeker A, Baid K, Aftanas P, Nirmalarajah K, Maguire F, Kozak R, McDonald R, Lang A, Gerdts V, Straus SE, Gilbert L, Li AX, Mozafarihasjin M, Walmsley S, Gingras AC, Wrana JL, Mazzulli T, Colwill K, McGeer AJ, Mubareka S, Falzarano D. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants. bioRxiv. Le 13 janvier 2022. doi : 10.1101/2022.01.13.475409

Kronfi N, Dussault C, Maheu-Giroux M, Halavrezos A, Chalifoux S, Sherman J, Park, H, Del Balso L, Cheng MP, Poulin S, Cox J. Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021), Clin Infect Dis, 2022; ciac031, https://doi.org/10.1093/cid/ciac031

Mwimanzi FM, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Datwani S, Omondi HF, Burns L, Young L, Leung V, Ennis S, Agafitei O, Basra S, Lim LY, Ng K, Pantophlet R, Brumme CJ, Montaner JSG, DeMarco M, Holmes D., Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA. Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third Dose. medRxiv. Le 6 janvier 2022. doi : 10.1101/2022.01.06.22268745

Zhang A, Breznik JA, Clare R, Nazy I, Miller MS, Bowdish DME, Costa AP. COVID-in-LTC Study Group. Antibody Responses to 3rd Dose mRNA Vaccines in Nursing Home and Assisted Living Residents. medRxiv, décembre 2021. doi : https://doi.org/10.1101/2021.12.17.21267996

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay J, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong J. Effectiveness of COVID-19 vaccines against Omicron or Delta infection. medRxiv 2021. doi : https://doi.org/10.1101/2021.12.30.21268565

Duarte N, Yanes-Lane M, Arora RK, Bobrovitz N, Liu M, Bego MG, Yan T, Cao C, Gurry C, Hankins CA, Cheng MP, Gingras AC, Mazer BD, Papenburg J, Langlois MA. Adapting serosurveys for the SARS-CoV-2 vaccine era. Open Forum Infect Dis, 2021; ofab632. doi : https://doi.org/10.1093/ofid/ofab632

Kim GN, Choi JA, Wu K, Saeedian N, Yang E, Park H, Woo SJ, Lim G, Kim SG, Eo SK, Jeong HW, Kim T, Chang JH, Seo SH, Kim NH, Choi E, Choo S, Lee S, Winterborn A, Li Y, Parham K, Donovan JM, Fenton B, Dikeakos JD, Dekaban GA, Haeryfar SMM, Troyer RM, Arts EJ, Barr SD, Song M, Kang CY. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS Pathogens. Le 16 décembre 2021;17(12):e1010092. doi : 10.1371/journal.ppat.1010092

Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC. Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study. BMJ Open 2021; 11:e052019. doi : 10.1136/bmjopen-2021-052019

Zinszer K, McKinnon B, Bourque N, Pierce L, Saucier A, Otis A, Cheriet I, Papenburg J, Hamelin ME, Charland K, Carbonneau J, Zahreddine M, Savard A, Fortin G, Apostolatos A, Haley N, Ratté N, Laurin I, Nguyen CT, Conrod P, Boivin G, De Serres G, Quach C; Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada. JAMA Network Open 4.11 (2021):e2135975-e2135975.

Bergeri I, Whelan M, Ware H, Subissi L, Nardone A, Lewis HC, Li Z, Ma X, Valenciano M, Cheng B, Al Ariqi L, Rashidian A, Okeibunor J, Azim T, Wijesinghe Le LV, Vaughan A, Pebody R, Vicari A, Yan T, Yanes-Lane M, Cao C, Cheng MP, Papenburg J, Buckeridge D, Bobrovitz N, Arora RK, van Kerkhove MD, Unity Studies Collaborator. Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020-Oct 2021. GroupmedRxiv 2021.12.14.21267791; doi : https://doi.org/10.1101/2021.12.14.21267791

Cao H, Mai J, Zhou Z, Li Z, Duan R, Watt J, Chen Z, Bandara RA, Li M, Ahn SK, Poon B, Christie-Holmes N, Gray-Owen SD, Banerjee A, Mossman K, Kozak R, Mubareka S, Rini JM, Hu J, Liu J. Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2. Cell Biosci. Le 8 décembre 2021;11(1):202. doi: 10.1186/s13578-021-00723-0. PMID : 34879865; PMCID : PMC8653804.

Costiniuk CT, Singer J, Langlois M, Kulic I, Needham J, Burchell A, Jenabian M, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme, Z, Brockman M, Margolese S, Mardarino E, Angel JB, Routy JP, Anis AH, Cooper C. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study. BMJ Open 2021;11:e054208. doi : 10.1136/bmjopen-2021-054208

Law JC, Girard M, Chao GYC, Ward LA, Isho B, Rathod B, Colwill K, Li Z, Rini JM, Yue FY, Mubareka S, McGeer AJ, Ostrowski MA, Gommerman JL, Gingras A-C, Watts TH. Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset. J Immunol. Le 13 décembre 2021. doi : 10.4049/jimmunol.2100727.

Cholette F, Mesa C, Harris A, Ellis H, Cachero K, Lacap P, Galipeau Y, Langlois M-A, Gingras A-C, Yansouni CP, Papenburg J, Cheng MP, Chakraborty P, Stein DR, Caeseele PV, Bartlett S, Krajden M, Goldfarb D, McGeer A, Osiowy C, Hankins C, Mazer B, Drebot M, Kim J, pour le compte du Groupe de travail sur l’immunité face à la COVID-19 (GTIC). Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison. PLoS ONE. Le 7 décembre 2021. doi : 10.1371/journal.pone.0261003

Buchan SA, Yon Seo C, Johnson C, Alley S, Kwong JC, Nasreen S, Calzavara A, Lu D, Harris TM, Yu K, Wilson SE. Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval. medRxiv. Le 5 décembre 2021. doi : https://doi.org/10.1101/2021.12.02.21267156

Bettinger JA, De Serres G, Valiquette L, Sadarangani M, Muller MP, Vanderkooi OG, Kellner JD, Top KA, Isenor JE, McGeer A, Irvine M, Shulha H, Marty K. Canadian National Vaccine Safety (CANVAS) Network: Active Safety Surveillance on COVID-19 vaccines. Conférence canadienne sur l’immunisation. Le 8 décembre 2021.

Nasreen S, Calzavara A, Sundaram M, Macdonald SE, Righolt C, Pai M, Field T, Zhou LW, Wilson S, Kwong JC. Background rates of hospitalizations and emergency department visits for selected thromboembolic and coagulation disorders in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance. 2021. https://doi.org/10.1101/2021.04.02.21254856

Brockman MA, Mwimanzi F, Lapointe HR, Sang Y, Agafitei O, Cheung P, Ennis S, Ng K, Basra S, Lim LY, Yaseen F, Young L, Umviligihozo G, Omondi FH, Kalikawe R, Burns R, Brumme CJ, Leung V, Montaner JSG, Holmes D, DeMarco ML, Simons J, Pantophlet R, Niikura M, Romney MG, Brumme ZL. Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults. J Infect Dis. Le 9 décembre 2021. doi : https://doi.org/10.1093/infdis/jiab592

Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N et coll. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Sci Adv. Le 26 novembre 2021;7(48):eabj5629. doi : 10.1126/sciadv.abj5629.

Grunau B, Goldfarb DM, Asamoah-Boaheng M, Golding L, Kirkham TL, Demers PA, Lavoie PM. Immunogenicity of extended mRNA SARS-CoV-2 vaccine dosing intervals. JAMA. Le 3 décembre 2021. doi: 10.1001/jama.2021.21921

Galipeau Y, Siragam V, Laroche G, Marion E, Greig M, McGuinty M, Booth RA, Durocher Y, Cuperlovic-Culf M, Bennett SAL, Crawley AM, Giguère P, Cooper C, Langlois M-A. Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2. EBioMedicine. Décembre 2021; doi : doi.org/10.1016/j.ebiom.2021.103700

Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N et coll. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Sci Adv. Le 26 novembre 2021;7(48):eabj5629. doi : 10.1126/sciadv.abj5629.

Bobrovitz N, Noel KC, Li Z, Cao C, Deveaux G, Selemon A, Lane MY, Yan T, Arora RK. SeroTracker-ROB: reproducible decision rules for risk of bias assessment of seroprevalence studies. doi : https://doi.org/10.1101/2021.11.17.21266471

Grunau B, Asamoah-Boaheng M, Lavoie PM, Ehsanul Karim M, Kirkham T, Demers PA, Barakauskas V, Citlali Marquez A, Jassem AN, O’Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM. A Higher Antibody Response is Generated with a 6 – 7 Week (vs Standard) SARS-CoV-2 Vaccine Dosing Interval. Clin Infect Dis. Novembre 2021;X(X):ZZ-XX. doi : 10.1093/cid/ciab938.

Ferreira VH, Marinelli T, Ierullo M, Ku T, Hall VG, Majchrzak-Kita B, Kulasingam V, Humar A, Kumar D. SARS-CoV-2 infection induces greater T-cell responses compared to vaccination in solid organ transplant recipients. J Infect Dis. Le 5 novembre 2021. doi: 10.1093/infdis/jiab542.

Choi A, Mâsse LC, Bardwell S, Zhao Y, Xu YXZ, Markarian A, Coombs D, Watts A, Macdonald A, Dhillon N, Irvine M, O’Reilly C, Lavoie PM, Goldfarb D. Symptomatic and asymptomatic transmission of SARS-CoV-2 in K-12 schools, British Columbia, April to June 2021. medRxiv. Le 20 novembre 2021. doi.org/10.1101/2021.11.15.21266284

Shire ZJ, Reicherz F, Lawrence S, Sudan H, Golding L, Majdoubi A, Levett PN, Lavoie PM, Jacobson K. Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy. Gut. Le 23 novembre 2021. doi : 10.1136/gutjnl-2021-326196

McKinnon B, Quach C, Dubé E, Nguyen CT, Zinszer K. Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada: a cross-sectional study, Vaccine, doi: https://doi.org/10.1016/j.vaccine.2021.10.077

Kronfi N, Dussault C, Maheu-Giroux M, Halavrezos A, Chalifoux S, and Sherman J, Park, H, Del Balso L, Cheng MP, Poulin S, Cox J. Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study. Pre-print The Lancet, November 9 2021 Doi: http://dx.doi.org/10.2139/ssrn.3959665

Breznik JA, Zhang A, Huynh A, Miller MS, Nazy I, Bowdish DME, Costa AP, Antibody Responses 3-5 Months Post-Vaccination with mRNA-1273 or BNT163b2 in Nursing Home Residents, JAMDA, DOI: https://doi.org/10.1016/j.jamda.2021.10.001

MacDonald C, Demers PA, Grunau B, Goldfarb D, O’Neill D, Armour R, Kirkham TL; Mental Health and Life Satisfaction Among Canadian Paramedics during the COVID-19 Pandemic.

Madathil S, Siqueira WL, Marin LM, Sanaulla FB, Faraj N, Quiñonez CR, et al. The incidence of COVID-19 among dentists practicing in the community in Canada: A prospective cohort study over a six-month period. The Journal of the American Dental Association. J Am Dent Assoc; 2021; DOI: https://doi.org/10.1016/j.adaj.2021.10.006

Fu Z, Rais, Y, Drabovich AP. Immunoprecipitation-targeted proteomics assays facilitate rational development of SARS-CoV-2 serological diagnostics. medRxiv. 25 Oct 2021. doi: 10.1101/2021.10.25.21265408v1

Drews SJ, Abe KT, Hu Q, Samson R, Gingras AC, Colwill K, Rathod B, Wang J, Fazel‐Zarandi M, Yi QL, Robinson A. Resistance of SARS‐CoV‐2 Beta and Gamma variants to plasma collected from Canadian blood donors during the Spring of 2020. Transfusion. 2021 Oct 18. doi: 10.1111/trf.16713

Colwill K, Galipeau Y, Stuible M, Gervais C, Arnold C, Rathod B, Abe KT, Wang JH, Pasculescu A, Maltseva M, Rocheleau L, Pelchat M, Fazel-Zarandi M, Iskilova M, Barrios-Rodiles M, Bennett L, Yau K, Cholette F, Mesa C, Li AX, Paterson A, Hladunewich MA, Goodwin PJ, Wrana JL, Drews SJ, Mubareka S, McGeer AJ, Kim J, Langlois M-A, Gingras A-C, Durocher Y. A “Made-in-Canada” serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. bioRxiv. 2021 Oct 26. doi: 10.1101/2021.10.25.21265476v1

Demone JJ, Maltseva M, Nourimand M, Nasr-Sharif M, Galipeau Y, Langlois MA, MacLean AM. Plant-based production of SARS-CoV-2 antigens for use in a subunit vaccine. bioRxiv. 2021 Jan 1. doi: 10.1101/2021.10.17.464700

Mithani SS, Bota AB, Zhu DT, Wilson K. A scoping review of global vaccine certificate solutions for COVID-19. Hum Vaccin Immunother. 2021 Oct 6.  doi:10.1080/21645515.2021.1969849

Brumme ZL, Mwimanzi F, Lapointe HR, Cheung P, Sang Y, Duncan MC, Yaseen F, Agafitei O, Ennis S, Ng K, Basra S, Lim LY, Kalikawe R, Speckmaier S, Moran-Garcia N, Young L, Ali H, Ganase B, Umviligihozo G, Omondi FH, Atkinson K, Sudderuddin H, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, DeMarco ML, Simons J, Hedgcock M, Romney MG, Barrios R, Guillemi S, Brumme CJ, Pantophlet R, Montaner JSG, Niikura M, Harris M, Hull M, Brockman MA. Humoral immune responses to COVID-19 vaccination in people living with HIV on suppressive antiretroviral therapy. medRxiv. 2021 Oct 4. doi: https://doi.org/10.1101/2021.10.03.21264320

Merkley E, Loewen PJ. Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada. JAMA Netw Open. 2021 Sep 1;4(9):e2126635. doi: 10.1001/jamanetworkopen.2021.26635

Saeed S, O’Brien SF, Abe K, Yi O, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras A-C, Drews S. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard. PLOS ONE. 2021 Sep 23. doi: https://doi.org/10.1371/journal.pone.0257743

Ayoubkhani D, Pawelek P, Gaughan C. Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 août 2021. UK Office for National Statistics. Released: 16 September 2021

SARS-CoV-2–Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals. J Immunol October 4, 2021, ji2100606; DOI: https://doi.org/10.4049/jimmunol.2100606

Antia R, Halloran ME. Transition to endemicity: Understanding COVID-19, Immunity (2021). Immunity, 24 september 2021 doi: 10.1016/j.immuni.2021.09.019

Vinh DC, Gouin JP, Cruz-Santiago D, Canac-Marquis M, Bernier S, Bobeuf F, Sengupta A, Brassard JP, Guerra A, Dziarmaga R, Perez A, Sun Y, Li Y, Roussel L, Langelier J, Ke D, Arnoldd C, Pelchat M, Langlois MA, Zhang X, Mazer BD. Real-world serologic responses to Extended-interval and Heterologous COVID-19 mRNA vaccination in Frail Elderly-Interim report from a prospective observational cohort study. medRxiv 21 Sept 2021; doi: 10.1101/2021.09.16.21263704

Luong L, Beder M, Nisenbaum R, Orkin A, Wong J, Damba C, Emond R, Lena S, Wright V, Loutfy M, Bruce-Barrett C, Cheung W, Cheung YK, Williams V, Vanmeurs M, Boozary A, Manning H, Hester J, Hwang SW, 2021. Prevalence of SARS-CoV-2 infection among people experiencing homelessness in Toronto during the first wave of the COVID-19 pandemic. medRxiv, September 26, 2021. doi:10.1101/2021.09.21.21263713

Saeed S, O’Brien SF, Abe K, Yi O, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras A-C, Drews S. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard. PLOS ONE. 2021 Sep 23. doi: https://doi.org/10.1371/journal.pone.0257743

Skowronski DM, Setayeshgar S, Zou M, Prystajecky N, Tyson JR, Sbihi H, Fjell CD, Galanis E, Naus M, Patrick DM, El Adam S. Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including early variants of concern: a test-negative design, British Columbia, Canada. medRxiv. 2021 Sept 22. doi : 10.1101/2021.09.20.21263875

Yanling Liu, Patrick Budylowski, Shilan Dong, Zhijie Li, Sofiya Goroshko, Leslie Y. T. Leung, Eyal Grunebaum, Paolo Campisi, Evan J. Propst, Nikolas E. Wolter, James M. Rini, Amin Zia, Mario Ostrowski and Götz R. A. Ehrhardt. SARS-CoV-2–Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals. J Immunol October 4, 2021, ji2100606; DOI: https://doi.org/10.4049/jimmunol.2100606

Vinh DC, Gouin JP, Cruz-Santiago D, Canac-Marquis M, Bernier S, Bobeuf F, Sengupta A, Brassard JP, Guerra A, Dziarmaga R, Perez A, Sun Y, Li Y, Roussel L, Langelier J, Ke D, Arnoldd C, Pelchat M, Langlois MA, Zhang X, Mazer BD. Real-world serologic responses to Extended-interval and Heterologous COVID-19 mRNA vaccination in Frail Elderly-Interim report from a prospective observational cohort study. medRxiv 21 Sept 2021;doi: 10.1101/2021.09.16.21263704

Saeed S, O’Brien SF, Abe K, Yi O, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras A-C, Drews S. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard. PLOS ONE. 2021 Sep 23. doi: https://doi.org/10.1371/journal.pone.0257743

Tang X, Gelband H, Nagelkerke N, Bogoch II, Brown P, Morawski E, Tam T. COVID-19 vaccination intention during early vaccine rollout in Canada: a nationwide online survey. The Lancet Regional Health – Americas 2021:100055. doi : 10.1016/j.lana.2021.100055

Dick DW, Childs L, Feng Z, Li J, Röst G, Buckeridge DL, Ogden NH, Heffernan JM. Fall 2021 Resurgence and COVID-19 Seroprevalence in Canada Modelling waning and boosting COVID-19 immunity in Canada A Canadian Immunization Research Network Study. medRxiv 2021.08.17.21262188; doi : 10.1101/2021.08.17.21262188

Hogan CA, Jassem AN, Sbihi H, Joffres Y, Tyson JR, Noftall K, Taylor M, Lee T, Fjell C, Wilmer A, Galbraith J, Romney MG, Henry B, Krajden M, Galanis E, Prystajecky N, Hoang LMN. Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021. Emerg Infect Dis. Le 13 août 2021;27(11). doi : 10.3201/eid2711.211190

Lee BE, Sikora C, Faulder D, Risling E, Little LA, Qiu Y, Gao T, Bulat R, Craik S, Hrudey SE, Ohinmaa A, Estabrooks C, Gingras AC, Charlton C, Kim J, Wood H, Robinson A, Kanji JN, Zelyas N, O’Brien SF, Drews S, Pang XL. Early Warning and Rapid Public Health Response to Prevent COVID-19 outbreaks in long-term care facilities (LTCF) by Monitoring SARS-CoV-2 RNA in LTCF site-specific Sewage Samples and Assessment of Antibodies Response in this Population – Prospective Study Protocol. BMJ Open Le 20 août 2021;11(8):e052282. doi : 10.1136/bmjopen-2021-052282.

Rais Y, Fu Z, Drabovich AP. Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants. Clin Proteomics 2021;18:19. doi : 10.1186/s12014-021-09325-x

Tang X, Sharma A, Pasic M, Brown P, Colwill K, Gelband H, Birnboim HC, Nagelkerke N, Bogoch II, Bansal A, Newcombe L, Slater J, Rodriguez PS, Huang G, Fu SH, Meh C, Wu CN, Kaul R, Langlois MA, Morawski E, Hollander A, Eliopoulos D, Aloi B, Lam T, Abe KT, Rathod B, Fazel-Zarandi M, Wang J, Iskilova M, Pasculescu A, Caldwell L, Barrios-Rodiles M, Mohammed-Ali Z, Vas N, Santhanam DR, Cho ER, Qu K, Jha S, Jha V, Suraweera W, Malhotra V, Mastali K, Wen R, Sinha S, Reid A, Gingras AC, Chakraborty P, Slutsky AS, Jha P. SARS-CoV-2 Seroprevalence During the First and Second Pandemic Waves in Canada. Soc Sci Res Net. Le 12 août 2021. doi : http://dx.doi.org/10.2139/ssrn.3903944

Breznik JA, Zhang A, Huynh A, Miller MS, Nazy I, Bowdish DME, Costa AP, COVID in Long Term Care Study Group. Antibody responses 3-5 months post-vaccination with mRNA-1273 or BNT163b2 in nursing home residents. medRxiv. Le 19 août 2021. doi : https://doi.org/10.1101/2021.08.17.21262152

Abe KT, Hu Q, Mozafarihashjin M, Samson B, Rathod B, Chao G, Wang JH, Iskilova M, Pasculescu A, Fazel-Zarandi M, Li A, Paterson A, Green K, Gilbert L, Barati S, Haq N, Takaoka A, Takaoka JG, De Launay KQ, Fahim C, Sheikh-Mohamed S, Arita Y, Durocher Y, Marcusson EG, Gommerman JL, Ostrowski M, Colwill K, Straus SE, Wood H, McGeer AJ, Gingras AC. Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers. medRxiv. Le 8 août 2021. doi : www.medrxiv.org/content/10.1101/2021.08.06.21261721v1

Sheikh-Mohamed S, Chao GYC, Isho B, Zuo M, Nahass GR, Salomon-Shulman RE, Blacker G, Fazel-Zarandi M, Rathod B, Colwill K, Jamal A, Li Z, Quin de Launay K, Takaoka A, Garnham-Takaoka J, Fahim C, Paterson A, Xinliu Li A, Haq N, Barati S, Gilbert L, Green K, Mozafarihashjin M, Samaan P, Siqueira W, Mubareka S, Ostrowski M, Rini JM, Rojas OL, McGeer A, Weissman IL, Caspi Tal M, Straus S, Gingras AC, Gommerman JL. A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination. medRxiv 2021.08.01.21261297; doi : https://doi.org/10.1101/2021.08.01.21261297

Nikiforuk AM, McMillan B, Bartlett SR, Márquez AC, Pidduck T, Kustra J, Goldfarb DM, Barakauskas V, Sinclair G, Patrick DM, Sadarangani M, Ogilvie GS, Morshed M, Sekirov, Jassem AN. Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Measure SARS-CoV-2 Seroconversion and Humoral Immunogenicity of COVID-19 Vaccination. medRxiv. Le 31 juillet 2021. doi : https://doi.org/10.1101/2021.07.29.21261156

Khana MS, Allison PJ, Siqueira WL, McNally ME, Glogauer M, Quinonez C, Madathil SA. Prevalence of COVID-19 among Canadian Dentists in August 2020. Affiche 1917, présentée à la 99^e séance générale du congrès de l’Association internationale de recherches dentaires (AIRD). Du 21 au 24 juillet 2021.

Seth R, Allison PJ, Siqueira WL, McNally ME, Quinonez C, Glogauer M, Madathil SA. COVID-19 Anxiety syndrome among Canadian dentists during the pandemic. Affiche 1918, présentée à la 99^e séance générale du congrès de l’Association internationale de recherches dentaires (AIRD). Du 21 au 24 juillet 2021.

Hall VG, Ferreira VH, Ierullo M, Ku T, Marinelli T, Majchrzak-Kita B, Yousuf A, Kulasingam V, Humar A, Kumar D. Humoral and Cellular immune response and Safety of 2-dose SARS-CoV-2 mRNA-1273 (Moderna) vaccine in Solid Organ Transplant Recipients. Am J Transplant. date Juillet 2021 volume(number):pages. doi : link

Li X, Vanderloo LM, Maguire JL, Keown-Stoneman CDG, Aglipay M, Anderson LN, Cost KT, Charach A, Vanderhout SM, Birken CS, TARGet Kids! Collaboration, 2021. Public health preventive measures and child health behaviours during COVID-19: a cohort study. Can J Public Health. doi :10.17269/s41997-021-00549-w

Galipeau Y, Siragam V, Laroche G, Marion E, Greig M, McGuinty M, Booth RA, Durocher Y, Cuperlovic-Culf M, Bennett SAL, Crawley AM, Giguère P, Cooper C, Langlois M-A. Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2. MedRxiv 2021.07.16.21260079; doi : https://doi.org/10.1101/2021.07.16.21260079

McKinnon B, Quach C, Dubé E, Tuong Nguyen C, Zinszer K. Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada: a cross-sectional study. doi :https://doi.org/10.1101/2021.05.08.21256831

Williams C, Al-Bargash D, Macalintal C, Stuart R, Seth A, Latham J, Gitterman L, Fedsin S, Godoy M, Kozak R, Guthrie JL, Wood H, McGeer A, Hota S, Rea E. COVID-19 Outbreak Associated with a SARS-CoV-2 P. 1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program–Ontario, April-May 2021. Clin Infect Dis. Le 8 juillet 2021. DOI : https://doi.org/10.1093/cid/ciab617

Duarte N, D’Mello S, Duarte NA, Rocco S, Wyk JV, Pillai AA, Liu M, Williamson T, Arora RK. Uptake of SARS-CoV-2 workplace testing programs, March 2020 to March 2021. medRxiv. Le 3 juillet 2021. doi: 10.1101/2021.06.29.21259730.

Nasreen S, He S, Chung H, Brown KA, Gubbay JB, Buchan SA, Wilson SE, Sundaram ME, Fell DB, Chen B, Calzavara A, Austin PC, Schwartz KL, Tadrous M, Wilson K, Kwong JC. Effectiveness of COVID-19 vaccines against variants of concern, Canada. medRxiv. Le 3 juillet 2021. doi: 10.1101/2021.06.28.21259420.

Bobrovitz N, Arora RK, Cao C, Boucher E, Liu M, Donnici C, Yanes-Lane M, Whelan M, Perlman-Arrow S, Chen J, Rahim H, Ilincic N, Segal M, Duarte N, Van Wyk J, Yan T, Atmaja A, Rocco S, Joseph A, Penny L, Clifton DA, Williamson T, Yansouni CP, Evans TG, Chevrier J, Papenburg J, Cheng MP. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. PLOS One. 16(6):e0252617. doi : 10.1371/journal.pone.0252617.

Law JC, Girard M, Chao GYC, Ward LA, Isho B, Rathod B, Colwill K, Li Z, Rini JM, Yue FY, Mubareka S, McGeer AJ, Ostrowski MA, Gommerman JL, Gingras AC, Watts TH. Immunity to SARS-CoV-2 persists 9 months post-symptoms with an altered T cell phenotype compared to influenza A virus-specific memory. medrxiv. Le 10 juin 2021. doi: 10.1101/2021.06.08.21258518.

Kinloch NN, Ritchie G, Dong W, Cobarrubias KD, Sudderuddin H, Lawson T, Matic N, Montaner JSG, Leung V, Romney MG, Lowe CF, Brumme CJ, Brumme ZL. SARS-CoV-2 RNA quantification using droplet digital RT-PCR. J Mol Diagn. Le 29 mai 2021. doi : 10.1016/j.jmoldx.2021.04.014.

Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, Macdonald SE, Janjua NZ, Tadrous M, Kwong JC. Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada. BMJ.doi : https://doi.org/10.1136/bmj.n1943 

Costa AP, Manis DR, Jones A, Stall NM, Brown KA, Boscard V, Castellino A, Heckman GA, Hillmer MP, Ma C, Pham P, Rais S, Sinha SK, Poss JW. Facteurs de risque d’éclosion de SRAS-CoV-2 dans les résidences pour aînés en Ontario, au Canada: étude de cohorte à l’échelle de la population. JAMC. Le 21 juin 2021;193(25):E969-77. doi: 10.1503/cmaj.202756-f.

Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Irvine MA, Reicherz F, Coombs D, O’Reilly C, Sediqi S, Razzaghian HR, Sadarangani M, O’Brien SF, Lavoie PM. SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada. medRxiv. Le 18 juin 2021. doi: 10.1101/2021.06.16.21258861.

Law JC, Girard M, Chao GYC, Ward LA, Isho B, Rathod B, Colwill K, Li Z, Rini JM, Yue FY, Mubareka S, McGeer AJ, Ostrowski MA, Gommerman JL, Gingras A-C, Watts TH. Immunity to SARS-CoV-2 persists 9 months post-symptoms with an altered T cell phenotype compared to influenza A virus-specific memory. medRxiv. Le 10 juin 2021. doi: 10.1101/2021.06.08.21258518.

Matic N, Lowe CF, Ritchie G, Stefanovic A, Lawson T, Jang W, Young M, Dong W, Brumme ZL, Brumme CJ, Leung V, Romney MG. Rapid detection of SARS-CoV-2 variants of concern identifying a cluster of B.1.1.28/P.1 variant in British Columbia, Canada. Emerg Infect Dis. Le juin 2021;27(6):1673-1676. doi: 10.3201/eid2706.210532.

Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, Macdonald SE, Janjua NZ, Tadrous M, Kwong JC. Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes in Ontario, Canada. Le 28 mai 2021. doi: 10.1101/2021.05.24.21257744.

Saeed S, O’Brien SF, Abe K, Yi O, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras A-C, Drews S. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard. medRxiv. 12 mai 2021. doi: 10.1101/2021.05.11.21256992.

Anand SP, Prévost J, Nayrac M, Beaudoin-Bussières G, Benlarbi M, Gasser R, Brassard N, Laumaea A, Gong SY, Bourassa C, Brunet-Ratnasingham E, Medjahed E, Gendron-Lepage G, Goyette G, Gokool L, Morrisseau C, Bégin P, Martel-Laferrière V, Tremblay C, Richard J, Bazin R, Duerr R, Kaufmann D, Finzi A.  Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset. Cell Rep Med. Le 4 mai 2021. doi: 10.1016/j.xcrm.2021.100290.

Tang X, Gelband H, Nagelkerke N, Bogoch I, Brown PE, Morawski E, Lam T, Reid A, Jha P. Quantifying COVID-19 vaccination hesitancy during early vaccination rollout in Canada. medRxiv [Preprint]. Le 2 mai 2021. doi: 10.1101/2021.04.29.21256333.

Flood CM, Thomas B, Wilson K. Vaccination obligatoire des travailleurs de la santé: analyse juridique et politique. CMAJ. Le 26 avril 2021 Avr. 26;193(17):E629-33. doi: 10.1503/cmaj.202755-f.

Huynh A, Arnold DM, Smith JW, Moore JC, Zhang A, Chagla Z, Harvey BJ, Stacey HD, Ang JC, Clare R, Ivetic N, Chetty VT, Bowdish DME, Miller MS, Kelton JG, Nazy I. Characteristics of anti-SARS-CoV-2 antibodies in recovered COVID-19 subjects. Viruses. Le 16 avril 2021. 16;13(4):697. doi: 10.3390/v13040697.

Zinszer K, McKinnon B, Bourque N, Zahreddine M, Charland K, Papenburg J, Fortin G, Hamelin ME, Saucier A, Apostolatos A, Pierce L, Savard-Lamothe A, Carbonneau J, Conrod P, Haley N, Laurin I, Boivin G, Serres GD, Quach C. Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: Protocol for a cohort study in Montreal, Canada. medRxiv [Preprint]. Le 16 avril 2021. doi: 10.1101/2021.04.14.21255499.

Brockman MA, Mwimanzi F, Sang Y, Ng K, Agafitei O, Ennis S, Lapointe H, Young L, Umviligihozo G, Burns L, Brumme CJ, Leung V, Montaner JSG, Holmes D, DeMarco M, Simons J, Niikura M, Pantophlet R, Romney MG, Brumme ZL. Weak humoral immune reactivity among elderly residents of long-term care facilities following one dose of BNT162b2 mRNA COVID-19 vaccine. medRxiv [Preprint]. Le 24 mars 2021. doi: 10.1101/2021.03.17.21253773

Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, Helen Stone, Maolin Lu, Sai Priya Anand, Guillaume Beaudoin-Bussières, Mehdi Benlarbi, Shilei Ding, Romain Gasser, Corby Fink, Yaozong Chen, Alexandra Tauzin, Guillaume Goyette, Catherine Bourassa, Halima Medjahed, Matthias Mack, Kunho Chung, Craig B Wilen, Gregory A. Dekaban, Jimmy D. Dikeakos, Emily A. Bruce, Daniel E Kaufmann, Leonidas Stamatatos, Andrew T. McGuire, Jonathan Richard, Marzena Pazgier, Pamela J. Bjorkman, Walther Mothes, Andrés Finzi, Priti Kumar, Pradeep D. Uchil. Live imaging of SARS-CoV-2 infection in mice reveals neutralizing antibodies require Fc function for optimal efficacy. bioRxiv [Preprint]. Le 22 mars 2021. doi: 10.1101/2021.03.22.436337

Brunet-Ratnasingham E, Anand SP, Gantner P, Moquin-Beaudry G, Dyachenko A, Brassard N, Beaudoin-Bussières G, Pagliuzza A, Gasser R, Benlarbi M, Point F, Prévost J, Laumaea A, Niessl J, Nayrac M, Sannier G, Boutin M, Descôteux-Dinelle J, Gendron-Lepage G, Goyette G, Bourassa C, Medjahed H, Orban C, Butler-Laporte G, Morrison D, Zhou S, Nakanishi T, Laurent L, Richard J, Dubé M, Fromentin R, Rébillard R-M, Arbour N, Prat A, Larochelle C, Durand M, Richards JB, Chassé M, Tétreault M, Chomont N, Finzi A, Kaufmann DE. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. medRxiv [Preprint]. Le 20 mars 2021. doi: 10.1101/2021.03.18.21253907

Majdoubi A, Michalski C, O’Connell SE, Dada S, Narpala S, Gelinas J, Mehta D, Cheung C, Winkler D, Basappa M, Liu  AC, Görges M, Barakauska VE, Irvine M, Mehalko J, Esposito D, Sekirov I, Jassem AN, Goldfarb DM, Pelech S, Douek DC, McDermott AB, Lavoie PM. A majority of uninfected adults show pre-existing antibody reactivity against SARS-CoV-2. JCI Insight. Le 15 mars 2021. doi: 10.1172/jci.insight.146316.

Castonguay N, Zhang W, Langlois M-A. Meta-analysis of the dynamics of the emergence of mutations and variants of SARS-CoV-2. medRxiv [Preprint]. Le 8 mars 2021. doi: 10.1101/2021.03.06.21252994

Tang X, Sharma A, Pasic M, Colwill K, Birnboim Ch, Nagelkerke Nico, Bogoch I, Schultz C, Newcombe L, Slater J, Rodriguez P, Huang G, Fu SH,  Meh C, Wu ChN,  Kaul R, Langlois MA, M E, Hollander A, Eliopoulos D, Aloi B, Lambe T, AbeK, Caldwell L, Barrios-Rodiles M,  Fazel-Zarandi M, Weingust R, Wang J, Rathod B, Santhanam DR, Cho ER, Qu K, Jha S, Jha V, Suraweera W,  Wen R, Sinha SR, Gingras AC, Chakraborty P, Slutsky  AS, Jha P. COVID symptoms, seroprevalence, and mortality during the first wave of SARS-CoV-2 in Canada. medRxiv [Preprint]. Le 5 mars 2021. doi: 10.1101/2021.03.04.21252540.

K Wilson and C Flood. Implementing digital passports for SARS-CoV-2 immunization in Canada. CMAJ. Le 2 mars 2021;193(10). doi: 10.1503/cmaj.210244.

Rébillard RM, Charabati M, Grasmuck C, Filali-Mouhim A, Tastet O, Brassard N, Daigneault A, Bourbonnière L, Anand SP, Balthazard R, Beaudoin-Bussières G, Gasser R, Benlarbi M, Carmena Moratalla A, Carpentier Solorio Y, Boutin M, Farzam-Kia N, Descôteaux-Dinelle J, Fournier AP, Gowing EM, Laumaea A, Jamann H, Lahav B, Goyette G, Lemaître F, Mamane VH, Prévost J, Richard J, Thai K, Cailhier JF, Chomont N, Finzi A, Chassé M, Durand M, Arbour N, Kaufmann DE, Prat A, Larochelle C. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients. J Clin Invest. Le 26 février 2021;26:145853. doi: 10.1172/JCI145853

Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM. Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia. J Thromb Haemost. Le 27 février 2021. doi: 10.1111/jth.15283.

Papenburg J , Cheng MP , Corsini R, Caya C, Mendoza E, Manguiat K, Lindsay LF , Wood H, Drebot MA, Dibernardo A , Zaharatos G , Bazin R, Gasser R, Benlarbi M , Gendron-Lepage G, Beaudoin-Bussières G, Prévost J, Finzi A, Ndao M, Yansouni C.  Evaluation of a commercial culture-free neutralization antibody detection kit for severe acute respiratory syndrome-related coronavirus-2 and comparison with an anti-RBD ELISA assay. medRxiv [Preprint]. Le 20 février 2021. doi: 10.1101/2021.01.23.21250325.

Anand SP, Prévost J, Richard J, Perreault J, Tremblay T, Drouin M, Fournier MJ, Lewin A, Bazin R, Finzi A. High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples. Transfusion. Le 18 février 2021. doi: 10.1111/trf.16318.

Gasser R, Cloutier M, Prévost J, Fink C, Ducas É, Ding S, Dussault N, Landry P, Tremblay T, Laforce-Lavoie A, Lewin A, Beaudoin-Bussières G, Laumaea A, Medjahed H, Larochelle C, Richard J, Dekaban GA, Dikeakos JD, Bazin R, Finzi A. Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2. Cell Rep. Le février 2021. 10:108790. doi: 10.1016/j.celrep.2021.108790.

Flood C, Thomas B, Wilson K. Mandatory vaccination for health care workers: an analysis of law and policy. CMAJ. Le 8 février 2021. 8;193(6). doi.org/10.1503/cmaj.202755.

Saeed S, Drews SJ, Pambrun C, Yi QL, Osmond L, O’Brien SF. SARS‐CoV‐2 seroprevalence among blood donors after the first COVID‐19 wave in Canada. Transfusion. Le 1 février 2021. doi: 10.1111/trf.16296.

Bolotin S, Tran V, Osman S, Brown KA, Buchan SA, Joh E, Deeks SL, Allen VG. SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline. J Infect Dis. Le 5 janvier 2021:jiaa796. doi: 10.1093/infdis/jiaa796.

Law JC, Koh WH, Budylowski P, Lin J, Yue F, Abe KT, Rathod B, Girard M, Li Z, Rini JM, Mubareka S, McGeer A, Chan AK, Gingras AC, Watts TH, A Ostrowski M. Systematic examination of antigen-specific recall T cell responses to SARS-CoV-2 versus influenza virus reveals a distinct inflammatory profile. J Immunol. Le 1 janvier 2021;206(1):37-50. doi: 10.4049/jimmunol.2001067.

Lu M, Uchil PD, Li W, Zheng D, Terry DS, Gorman J, Shi W, Zhang B, Zhou T, Ding S, Gasser R, Prévost J, Beaudoin-Bussières G, Anand SP, Laumaea A, Grover JR, Liu L, Ho DD, Mascola JR, Finzi A, Kwong PD, Blanchard SC, Mothes W. Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles. Cell Host & Microbe. Le 9 décembre 2020;28(6):880-891. doi: 0.1016/j.chom.2020.11.001.

Ding S, Laumaea A, Benlarbi M, Beaudoin-Bussières G, Gasser R, Medjahed H, Pancera M, Stamatatos L, McGuire AT, Bazin R, Finzi A. Antibody binding to SARS-CoV-2 S glycoprotein correlates with but does not predict neutralization. Viruses. Le 26 octobre 2020; 12(11):1214. doi: 10.3390/v12111214.

Prévost J, Gasser R, Beaudoin-Bussières G, Richard J, Duerr R, Laumaea A, Anand SP, Goyette G, Benlarbi M, Ding S, Medjahed H, Lewin A, Perreault J, Tremblay T, Gendron-Lepage G, Gauthier N, Carrier M, Marcoux D, Piché A, Lavoie M, Benoit A, Loungnarath V, Brochu G, Haddad E, Stacey HD, Miller MS, Desforges M, Talbot PJ, Maule GTG, Côté M, Therrien C, Serhir B, Bazin R, Roger M, Finzi A. Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike. Cell Rep Med. Le 20 octobre 2020;1(7):100126. doi: 10.1016/j.xcrm.2020.100126.

Beaudoin-Bussières G, Laumaea A, Anand SP, Prévost J, Gasser R, Goyette G, Medjahed H, Perreault J, Tremblay T, Lewin A, Gokool L, Morrisseau C, Bégin P, Tremblay C, Martel-Laferrière V, Kaufmann D, Richard J, Bazin R, Finzi A. Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals. mBio. Le 16 octobre 2020. doi: 10.1128/mBio.02590-20.

Anand SP, Chen Y, Prévost J, Gasser R, Beaudoin-Bussières G, Abrams CF, Pazgier M, Finzi A. Interaction of human ACE2 to membrane-bound SARS-CoV-1 and SARS-CoV-2 S glycoproteins. Viruses. Le 29 septembre 2020;12(10):1104. doi: 10.3390/v12101104.

Arora RK, Joseph A, Van Wyk J, Rocco S, Atmaja A, May E, Yan T, Bobrovitz N, Chevrier J, Cheng MP, Williamson T. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard. Lancet Infect Dis. Le aout 2020. doi: 10.1016/S1473-3099(20)30631-9